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Cystic fibrosis (CF) remains an incurable life limiting condition, which is the most 
common inherited lethal condition in Western countries. Despite the advances made 
in the general care of CF patients, modem research has been aimed at advances in 
the management of the respiratory infection, which is the main cause of the high 
mortality and morbidity rate among these patients. The normal respiratory 
epithelium serves as a dynamic barrier, participating in innate immunity and 
regulation of acquired immunity. Cystic fibrosis is a disease that primarily involves 
epithelia as a result of mutations of the cystic fibrosis transmembrane conductance 
regulator (CFTR), which is expressed in the apical epithelial membranes. Mutations 
in CFTR impair chloride transport and lead to an environment favoring colonization 
by pathogenic bacteria. In addition, there are other components that could lead to 
enhancement of bacterial infections. Respiratory inflammation and lack of nitric 
oxide are two important components that play a major role in the pathology of CF 
lung disease.
Using a pulmonary epithelial cell line, A549, the modulation of the production of 
nitric oxide (NO) was examined. These cells were found to produce NO with 
specific combinations of the pro-inflammatory cytokines interleukin (IL)-lp, 
interferon-y (IFN), and tumour necrosis factor (TNF)-a. This NO generation was a 
result of activity of inducible nitric oxide synthase (iNOS). Modulation of this 
activity was achieved using the T cell-derived anti-inflammatory cytokine, IL-13, 
which significantly reduced NO generation. IL-13 was found to modulate iNOS 
activity in a PI 3-kinase dependent manner, and not via up-regulation of arginase. 
Pulmonary colonization in CF patients with Burkholderia cepacia strains leads not 
only to a decline in respiratory function but also, in some cases, to acute systemic 
infection. Other patients exhibit persistent colonization with B. cepacia without 
deterioration of the respiratory system. Differences in catalase activities, that allow 
B. cepacia to resist oxidative killing, were observed from planktonic and biofilm 
cells and were consistent with susceptibility of strains to oxidative killing by H2O2 . 
The biofilm cells had reduced catalase activity and were more susceptible to
oxidative killing. A fragment of the catalase gene of the clinical isolate B. cepacia 
J2315 strain was isolated, cloned and sequenced based on homology to the catalase 
(ICatE) o f Escherichia coli and Pseudomonas aeruginosa.
The two parts of this work aimed to highlight methods that may contribute to a 
better management o f the respiratory tract infections in CF patients through the 
modulation of reactive nitrogen species and reactive oxygen species.
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Cystic fibrosis (CF) is the most common life-shortening genetic disorder in 
individuals of Northern Europe. It was in 1938 when Dr. Dorthea Anderson first 
coined the term “cystic fibrosis in pancreas” to describe pancreatic lesions associated 
with the disease. CF is a result of a recessive mutation in a single gene that encodes 
the cystic fibrosis transmembrane conductance regulator (CFTR). The gene product 
(CFTR) is expressed in the apical epithelial membranes, which makes it a disease that 
primarily involves epithelia. Mutations of the CFTR gene cause abnormal salt 
transport, particularly chloride (CT), in the epithelia of the respiratory, hepatobilary, 
gastrointestinal, and reproductive tracts and the pancreas. The decrease in chloride 
transport is accompanied by decreased transport of sodium and water, resulting in 
dehydrated, viscous secretions that are associated with luminal obstruction and 
destruction and scarring of various exocrine glands (Welsh and Ramsey, 1998). As a 
result, the clinical manifestations of CF include pancreatic insufficiency in 80 to 90 
percent of patients with a mutated CFTR gene, meconium ileus in 17 percent of 
affected newborns, diabetes mellitus associated with pancreatic disease in 20 percent 
of affected adults, obstructive biliary tract disease in 15 to 20 percent of all patients, 
and ozzospermia in more than 90 percent of affected men. The primary cause of 
morbidity and mortality in CF patients, however, is lung dysfunction, which accounts 
for over 90 percent of fatalities (Wood and Editor, 1996). In contrast to the lung, 
recurrent infection and inflammation is not a feature of CF in other organs. This 
indicates that there is a defect in local pulmonary defence mechanisms. Hypotheses
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that explain the pathogenesis of CF lung disease need to correlate genetic mutation, 
inflammation, and infection. These are the cornerstones of understanding of CF lung 
infection.
1.2 The cystic fibrosis gene
The CF gene was identified in 1989. It is located on the long arm of chromosome 7, 
spans 250 kb of genomic DNA and contains 27 exons. The CF gene encodes a 1480- 
amino acid long transmembrane protein with asymmetrical structure (Riordan et aL, 
1989; Rommens et al., 1989; Kerem et al., 1989). The protein was named cystic 
fibrosis conductance regulator (CFTR) reflecting the function of the protein, which is 
the regulation of chloride (CF) channels (Collins, 1992) (Fig. 1.1). It is a multidomain 
protein subject to complex regulation. As a result, mutations in the CF gene can 
disrupt CFTR function by several different mechanisms according to their nature and 
where the mutation occurs (Vankeerberghen et al., 2001). Accordingly, there are five 
main classes of mutations. Extensive population studies revealed that there are more 
than 1,000 different mutations (see CFTR mutation database at 
(http://www.genet.sickkids.on.ca/cftr/) (Pitt, 2001). The most common mutation 
among CF is a 3-bp deletion in exon 10 of the CF gene. This results in the loss of a 
single amino acid, phenylalanine at position 508 (AF508). CF mutations vary from 
nonsense, missense, ffameshift and mRNA splice mutation. Most, but not all, of the 




Fig. 1.1. Model showing the proposed domain structure of 
CFTR.. TMD, transmembrane domain; NBD,nucleotide- 
binding domain; R, regulatory domain; and PKA, cAMP- 
dependent protein kinase A.
Adapted from Welsh and Ramsey (1985).
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1.2.1 The function of CFTR protein
Normal CFTR is an ATPase/ABC-transporter that functions as a channel for charged 
anions, such as chloride ions, to be selectively transported across the apical membrane 
of epithelial cells. There are two transmembrane domains (TMD) containing six 
transmembrane helices (TM), two nucleotide-binding domains (NBD) and a large 
hydrophilic regulatory (R) domain. Multiple kinases can activate the CFTR chloride 
channel, however, only protein kinase A (PKA) has been studied in detail 
(Vankeerberghen et al., 2001). A simplified model of CFTR gating is given in (Fig. 
1.2). It starts with phosphorylation of the R domain by cAMP-dependent PKA, which 
has a stimulatory role by enhancing the interaction of ATP with the nucleotide binding 
domains. These NBD hydrolyze ATP to control channel opening and closing (Cheng 
et a l, 1991). The channel opens and anions flow, according to the electrochemical 
gradient, through the pore formed by the TMDs. Once the R domain is 
dephosphorylated by phosphatases, the channel closes (Vankeerberghen et al., 2001).
1.2.2 The secondary function of the CFTR
CFTR acts as a regulatory switch, since it regulates other ion channel proteins. It can 
negatively regulate the sodium (Na+) transport by downregulating the amiloride 
sensitive epithelium sodium channel (ENaC) (Boucher et al., 1986). As CFTR 
facilitates ATP release across membranes, it positively regulates the outwardly 
















2 A DP 
+ Pi
Fig. 1.2. A model of CFTR channel gating. Activation of the CFTR chloride 
channel starts after cyclic AMP stimulates PKA to phosphorylate the R domain 
(step 1), the CFTR channel is poised to bind ATP (step 2), which is cleaved to 
induce conformational charge (step 3), opening the chloride channel. Pi, inorganic 
phosphate; cAMP, cyclic AMP; PKA, protein kinase A; TMD, Transmembrane 
domain; NBD, nucleotide binding domain; R, regulatory domain and Cl- , chloride 
ion. Adapted from Collins (1992).
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1.2.3 Classes of CF gene defect
There are a variety of mechanisms by which mutations in the CF gene can result in 
quantitative or qualitative reductions in CFTR of CF patients. These mechanisms may 
be classified into five general categories, which are not mutually exclusive (Hilman 
and Constantinescu, 1999) (Fig. 1.3).
1- Class I mutations: These result in the formation of unstable/truncated CFTR 
mRNA, caused either by a base substitution that creates a premature stop codon, or 
by frameshift mutation. The resulting proteins either degrade rapidly or have little or 
no function. The disease phenotype of this class is often severe.
2-.Class II mutations: The majority of CF mutations, including the most frequent one 
AF508, are in this class. They lead to the production of an immature protein, due to 
defective processing or trafficking. The CFTR protein does not reach the apical 
membrane. The disease phenotype of this class is often severe.
3- Class III mutations: Interference with regulation of the chloride channel even 
though the protein reaches the apical membrane. It results in a decrease in the net 
chloride transport activity of the channel. This can also be a severe disease 
phenotype.
4- Class IV mutations: This class of mutations affects amino acids located in the pore 
of the channel. CFTR reaches the apical membrane but conduction is defective owing 




5- Class V mutations: These lead to a decreased level of normal CFTR by mutations 
in the CF gene promoter. A CF phenotype may be produced if the reduction in CFTR 
is greater than 10%.
Patients with heterozygous mutations typically have the disease characteristics of the 
‘milder’ mutation, due to the recessive nature of the disease (Vankeerberghen et al., 
2001)
1.3 Respiratory inflammation in cystic fibrosis
Respiratory inflammation is the most serious and common feature of early CF. 
Evidence suggest that this inflammation is not secondary to bacterial infection but 
rather supports the idea that dysregulation of the inflammatory response is an intrinsic 
component of the CF phenotype (Cantin, 1995). This report suggests a new model 
that links mutations of the CFTR and intracellular signal transduction, resulting in an 
exaggerated inflammatory response that is mediated, in part, through NF-kB. As a 
result, respiratory tract inflammation may occur prior to or in the absence of bacterial 
infection (Weber et al., 2001). Armstrong and colleagues in 1997 found out that 
airway inflammation in infants and young children precedes respiratory infection. 
Their findings were supported by a longitudinal bronchoalveolar lavage (BAL) study 
of infants with CF who improved when pathogens are eradicated (Armstrong et al., 
1997). However, significant regional variability of lung inflammation in CF on BAL 
may suggest the possibility that Armstrong’s findings may be insufficiently sensitive 
to detect infection (Meyer and Sharma, 1997). It is clear that in most studies made, 





Normal I. No synthesis II. Processing blocked
Deletion A F508
III. Regulation blocked 
Missense G551D
IV. Conductance altered 
Missenese B117B
V. Synthesis reduced 
Missense A455A
Fig.1.3. Classes of mutation affecting CFTR. Wild type CFTR is transcribed in the 
nucleus and processed in the Golgi and ER where it is inserted into vesicle memb­
ranes and transported to the apical epithelial cell surface to form a functional chlor­
ide channel. Five classes of mutations of cystic fibrosis transmembrane conductance 
regulator (CFTR) gene and proposed functions. The type of functional alterations of 
the chloride channel activity of CFTR due to each class mutation are illustrated. 
Class I, the mutations affect biosynthesis and no functional protein is 
synthesised ; Class II, mutations affect protein maturation and there are alteration 
in processing; Class III, mutations affect chloride channel regulation; Class IV, 
mutations affect chloride channel conductance; Class V. mutations cause reduced 
synthesis. TMD, transmembrane domain; MSD, nucleotide binding domain;




simultaneously in one group of infants, which would have given a better 
understanding of these relationships in early lung disease. In a recent study an attempt 
to investigate the effect of lower airway infection on clinical parameters, pulmonary 
function tests and inflammation in clinically stable infants and young children with 
CF, found a relationship between the bacterial lower respiratory tract infection and 
the presence of inflammation and abnormal pulmonary function (Dakin et ah, 2002). 
Cytokine analysis of bronchoalveolar lavage fluids (BALF) has revealed elevated 
levels of the pro-inflammatory cytokines tumor necrosis factor-a (TNF-a), 
interleukin-1 (3 (IL-P) and IL-6 compared with healthy controls and other diseases in 
which there is bacterial infection in the lung (Bonfield et al., 1995; Wilmott et al., 
1990). This increase in cytokine production in the CF airway is in part driven by 
lipopolysaccharide of pathogenic Gram-negative bacteria (Bonfield et al., 1995). 
Moreover, observations concerning the role of respiratory inflammation in the 
development of CF respiratory disease indicate that epithelial cells recruit neutrophils 
locally through directed interleukin-8 (IL-8) secretion. Increased levels of IL-8, a pro- 
inflammatory chemokine that accounts for most of the neutrophil chemoattractant 
activity, have been shown from sputum and BALF of CF patients (Muhlebach. et al., 
1999; Armstrong et al., 1997). On the other hand, some studies suggest that IL-8 
production by CF respiratory epithelial cells is defective (Massengale et al., 1999; 
Denning, et al., 1998). Recently it has been demonstrated that defective CFTR 
function may result in increased NF-kB activation which may in turn result in 




Interleukin-10 (IL-10) is an anti-inflammatory cytokine mediator constitutively 
produced by bronchial epithelial cells from normal individuals, that reduces 
production of TNF-a and IL-lp by macrophages, but is significantly absent in CF 
cells (Bonfield et al., 1995). Thus, it might be predicted that absence of this cytokine 
causes the inflammatory response to be uncontrolled, resulting in increased intensity 
of lung injury (Massengale et al., 1999; Bonfield et al., 1995). A recent study 
demonstrated that immunoregulatory abnormalities caused by insufficient IL-10 not 
only affect the suppression of synthesis of pro-inflammatory cytokines, but would 
also alter the immunogenic function of macrophages (Soltys et al., 2002).
1.3.1 The immune response and inflammation in CF respiratory tract
The primary function of the respiratory system is oxygenation of the blood and 
removal of carbon dioxide. This requires that air be brought into close proximity with 
blood. Accordingly, the respiratory tract is particularly exposed to infection either by 
microbes and airborne particles in inspired air or through the spread downward of 
bacterial cells commonly colonizing the nose and throat. As these agents are 
frequently deposited on the surface of the respiratory tract, efficient defence 
mechanisms are needed to avoid or minimise respiratory infections. The normal host 
defence of the respiratory system includes a rapid but non-specific reaction from 
components of the innate (non-specific) immune system (Zhang et al., 2000).
More than 7000 liters of air mixed with inorganic and organic particles enter the 
respiratory tract, yet normal humans rarely develop pulmonary infections. However, 
infections of the CF pulmonary system, which is structurally normal in utero and
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pathogen-free shortly after birth (Khan et al., 1995) is the major cause of morbidity 
and accounts for more than 90% of the mortality in CF (Fitzsimmons, 1993).
1.4 Immunity of the respiratory tract
A first line of defence against pathogenic insult is called the innate immune system, 
which is followed by acquired immune responses associated with activation of T and 
B cells to specific antigens. However, the innate immune response not only provides 
the first-line barrier to colonization and infection but also determines to which 
antigens the acquired immune system responds and the nature of these responses 
(Fearon and Locksley, 1996) (Fig. 1.4).
1.4.1 Innate (non-specific) immune response
1.4.1.1 Physical defence
The initial line o f defence for the respiratory tract is the barrier function of the ciliated 
epithelium. It effectively separates the luminal surface from the basolateral surface, 
via a mucus blanket which overlays a thin layer of airway surface liquid (ASL). Both 
mucus and ASL covers the surface of ciliated epithelia preventing bacterial 
adherence. Particles greater than 5pm in diameter are generally trapped in the 
mucociliary blanket. These mucus-trapped particles will be cleared by beating cilia, 
which propels the mucus up to the oropharynx for swallowing or expectoration 
(Zhang et al., 2000). In the CF respiratory tract, defective CFTR protein reduces the 
secretions of CF in the mucus layer and enhances Na+ absorption, which reduces the 






















Fig. 1.4. A model of the host innate defence mechanisms of the respiratory 
epithelium. Cough and cilia mechanically remove inhaled debris and 
microorganisms entrapped in mucus, a mechanism called mucociliary 
clearance. Multiple substances with pro- and anti-inflammatory as well 
as antimicrobial activities are secreted by epithelial cells and function as 
innate immune barrier. Macrophages, B and T lymphocytes, neutrophils 
and also epithelial cells represent cellular component of the innate and 
adaptive immune system. Adapted from Bals etal. (1999).
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evidence that CF epithelia hyperabsorb water (Matsui et al., 1999). Thus, CF patients 
with infected respiratory tracts generally produce sputum that is dehydrated and 
highly viscous. Another hypothesis to explain how a defect in CFTR results in a 
breach of the innate immunity was proposed by Smith et a l (1996). They 
demonstrated that elevated salt concentrations in the ASL diminished the antibacterial 
activity of substances present in ASL in vitro assays, which consequently affect 
bacterial killing of CF ASL. Further analysis of the sputum indicates a high content of 
cellular and bacterial debris, such as: actin, serum, protein, DNA, alginate, and 
rigidifying lipids. These negatively charged biopolymers (mucin, DNA, and alginate) 
form a viscoelastic network, which reduces the efficiency of the diffusion barrier for 
pathogens and harmful particles (Sanders et al., 2000), and reduces the ciliary beat 
frequency. This consequently impairs clearance of the mucus blanket.
1.4.1.2 Chemical defence
Particles less than 5 pm in diameter bypass the mucus barrier and may gain access to 
the terminal respiratory tract. To insure sterility of all parts of the respiratory tract, a 
wide range of peptides, proteins and organic molecules derived from secretory cells 
are found in the epithelia. These secretory cells include mucous and serous cells in 
submucosal glands, as well as goblet and clara cells in the epithelial layer. These 
substances either exert direct lethal activity or facilitate the elimination of infectious 
pathogens by phagocytosis. These include lysozyme, complement, immunoglobulin A 
and G, fibronectin, lactoferrin, transferrin, phospholipase A2, lipopolysaccharide 
(LPS)-binding protein, p-defensins, cathelicidins, collectins, leukoprotease inhibitor,
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peroxidase, reactive nitrogen species (RNS) and nitric oxide (NO) (Zhang et al., 2000; 
Diamond et al., 2000). In the normal respiratory tract the activity of some of these 
chemical is salt concentration-dependent. In CF the bactericidal activity of ASL was 
reduced as a result of the high NaCl concentration. For example, the low molecular 
weight, heat stable defensin molecule has a broad-spectrum antibacterial activity that 
is dependent on salt concentration (Bals et al., 1999). This salt-dependent inactivation 
of defensin has been proposed to play an important role in the pathogenesis of CF 
(Smith et al., 1996).
As part of the respiratory tract response to infection, two complementary inducible 
defence mechanisms have been observed. The first mechanism is the increased 
production of antimicrobial agents, and the second mechanism is the induction of a 
signaling network to recruit phagocytic cells to contain the infection. Constitutive 
peptides and proteins are up-regulated in response to inflammatory mediators, pro- 
inflammatory cytokines, like IL-lp, TNF-a, IFN-y, Gram-negative 
lipopolysaccharide (LPS), Gram-positive lipoteichoic acids, lipoarabinomannans of 
myobacteria, and bacterial-derived DNA and lipoproteins. Human P-defensin showed 
increased levels in inflamed respiratory cells in response to P. aeruginosa LPS, IL- 
ip, as well as TNF-a (Diamond et al., 1996; Russell et al., 1996). Other inducible 
host defence molecules include mucin and reactive nitrogen species such as nitric 
oxide (NO). Mucin levels are elevated in the BALF in response to Gram-negative and 
Gram-positive infections. Moreover, P. aeruginosa LPS induces mucin glycoprotein 




The production of reactive nitrogen species (RNS) in mammalian hosts appears to 
play a role either solely or in combination with other radicals in the defence against 
respiratory tract infection (Nathan and Hibbs, 1991; Nathan, 1992; Fang, 1997; 
Nathan and Shiloh, 2000). The increasing susceptibility of CF patients to persistent 
bacterial infections has been attributed, in part, to the low availability of RNS, and 
nitric oxide (NO) in particular (Kelley and Drumm, 1998; Meng et al., 1998). The 
following section will discuss the role of NO in immune response.
1.5 Nitric oxide and Reactive nitrogen species
In healthy human subjects, nitric oxide (NO) can be measured in exhaled breath. NO 
levels increase significantly in several lung diseases, notably asthma and 
bronchiectasis (Hamid et al., 1993), or after exposure to irritant gases such as ozone 
(Pendino et al., 1993). Nitric oxide is synthesised via constitutive or inducible forms 
of nitric oxide synthases (NOSs) (Section 1.5.1). The oxidative metabolism of NO 
involves a number of reactive nitrogen species (RNS) in which the oxidation state of 
nitrogen ranges from +1 to +5 (Table 1.1). Several of these species exhibit the various 
biological actions of NO. In human, RNS are released from several cell types within 
the respiratory tract, including airway and alveolar epithelial cells, macrophages, 
neutrophils, mast cells, and vascular endothelial and smooth-muscle cells. Production 
of NO is known to be constitutive in all areas of the healthy respiratory tract (van der 
Vliet etal., 1999).
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Symbol Name Oxidation state
N O ' Nitroxyl anion
+ 1




NO + Nitrosyl (nitrosonium) cation +3
N 0 2- Nitrite +3
n 2o 3 Dinitrogen trioxide +3
n o 2 Nitrogen dioxide +4
n 2o 4 Dinitrogen tetraoxide +4
ONOO" Poxynitrite +5
n o 2+ Nitryl (nitronium) cation +5
n o 3' Nitrate +5
Table 1.1. Types of biological reactive nitrogen species 
(RNS). Adapted from va der Vliet et al. (1999).
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1.5.1 NO: Chemical and biochemical basis of production
Nitric oxide is a radical gas, which has diverse biological functions in the 
cardiovascular, nervous and immune systems. NO is lipid and water-soluble and has a 
molecular weigh of 30-dalton with an apparent half-life between 6  and 60 seconds. It 
is synthesized from the amino acid L-arginine, by a family of enzymes called nitric 
oxide synthases (NOSs). There are three mammalian isoforms of NOS that catalyze 
the production of NO by the same biochemical pathway, which consists of two 
sequential monooxygenase reactions (Fig. 1.5). One molecule of L-arginine is 
oxidized at a guanidine nitrogen to produce A^-OH-L-arginine as an intermediate, 
which is further oxidized to yield one molecule each of NO and L-citrulline. This 
oxidation reaction needs NADPH and dioxygen as cosubstrates for NOS (Nathan, 
1992).
The three distinct human isoforms of NOS are products of three different genes, 
which share 51-57% homology. They differ in their localization, regulation, catalytic 
properties and inhibitor sensitivity. They can be divided into two main groups 
characterized broadly as the constitutive (cNOS) and inducible (iNOS) isoforms. The 
constitutive NOS isoforms are usually referred to as: neuronal NOS (nNOS, also 
known as Type I, NOS-I and NOS-1) being the isoform first found (and 
predominating) in neuronal tissue. Endothelial NOS (eNOS, also known as Type III, 
or NOS-III and NOS-3) is the isoform found in vascular endothelial cells. The third 
isoform is inducible NOS (iNOS), also known as type II, NOS-II and NOS2), which 
is inducible in a wide range of cells and tissues. The nNOS and eNOS are exquisitely 












Fig. 1.5. Biochemical pathway of NO production in mammalian 




for its activity. The subunit molecular mass of nNOS » 160 KDa, while eNOS and 
iNOS «130KDa (Knowles and Moncada, 1994; Stuehr, 1999).
It has been demonstrated that iNOS is induced by pro-inflammatory cytokines, viral 
infection and microbes or microbial products such as lipopolysaccharide of Gram- 
negative bacteria (Hoffman, 1996). Interestingly, variable immunostaining of airway 
epithelium revealed that iNOS is constitutively expressed in airway epithelial cells of 
normal, non-smoking individuals (Guo et al., 1995).
Once formed, NO diffuses to adjacent cells where it activates soluble guanylate 
cyclase, resulting in the formation of cyclic guanosine monophosphate (cGMP), 
which in turn mediates many, but not all, of the biological effects of NO. The specific 
activation of guanylate cyclase by NO is due to its ability to bind transition metal iron 
heme (Moncada and Higgs, 1993). Nitric oxide is relatively inocuous, unless it 
couples with other radical species, such as superoxide (O2-). This property allows it 
to function as a physiological messenger molecule and, under certain conditions, as a 
cytotoxic effecter molecule as well (Gross and Wolin, 1995).
In vivo NO can be detected as gas, which can react with O2 to form nitrite (NO2-), 
nitrate (NO3"), and nitroxyl (NO-) and intermediates such as nitrosonium (NO4), 
peroxynitrite (ONOO-) and nitrogen dioxide (-N0 2 ). Reaction of NO with hydrogen 
peroxide produces an singlet oxygen molecule, which is potentially toxic (Morcillo et 
a l, 1999) (Fig. 1.7). It is noteworthy that NO is not necessarily the first RNS 
intermediate formed. Nitric oxide synthesis is often secondary to the buildup of nitrite 
and nitrate, or from reactions with haem proteins, such as the oxidation of
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Fig. 1.6. Biosynthesis of nitric oxide (NO) from L-arginine (L-ARG). 
Release of NO activates guanylate cyclase in an acceptor cell leading to 




oxyhaemoglobin to methaemoglobin, or the stimulation of guanylate cyclase. 
Accordingly, other potential RNS reactions may lead to the formation of NO 
(Alderton et al., 2001). Thus, NOSs are not the only source of NO in exhaled air and 
as such its measurement may not be a direct measure of NOS activity in the lower 
respiratory tract.
Nitric oxide reacts with thiol-containing molecules such as cystein and glutathione to 
form S-nitroso proteins and S-nitrosothiol. S-nitrosothiol may function as a reservoir, 
or storage pool, for enzymatically synthesized NO. It was reported that 70 to 90% of 
NO is released from S-nitrosothiols, which are potent relaxants of the human airway. 
They may play an important role in sequestration, release, and transportation of NO 
to its site of action. In addition, NO gas may be released from nitrite protonation to 
form a nitrous acid in an acidic environment. This pH-related pathway has been 
implicated in asthma (Kharitonov and Barnes, 2001).
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Fig. 1.7. Reaction products of NO with oxygen or reactive oxygen species.
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1.5.2 Biological activity of NO
The activity of NO has been described as a double-edged sword, serving as a 
regulatory and/or potent anti-inflammatory molecule, as well as a toxic and/or pro- 
inflammatory molecule. The reason behind this contradictory property of NO is not 
entirely clear. However, the chemistry of NO and its metabolites may help identify 
which of the many NO-dependent reactions are important in modulating the 
inflammatory response (Grisham et al., 1999) (Fig. 1.8).
The biological actions of NO appear to be mediated by its ability to interact with 
paramagnetic centres in effector proteins, such as heme- or iron-sulfur centres. On the 
other hand, RNS are reactive toward all classes of biomolecules, such as transition- 
metal ions in metaleproteins, amino acid residues (thiols, amines, and tyrosine), 
unsaturated lipids, and DNA bases. Such interactions represents the cytotoxic and 
cytostatic processes associated with excessive NO production (van der Vliet et al., 
1999; Poole and Hughes, 2000).
In another attempt to classify NO physiological properties Grisham and colleagues 
(Grisham et al., 1999) considered the timing, location and the rate of production as a 
scheme to divide it into direct and an indirect effects (Fig. 1.9). Direct effects are 
those reactions in which NO interacts directly with a biological molecule or cellular 
target and are thought to occur under normal physiological conditions when NO 
fluxes are low. Indirect effects are those reactions mediated by NO-derived species
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Fig. 1.9. Physiological chemistry of NO. RNS, reactive nitrogen 
species. Adapted from Grisham et al. (1999).
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such as reactive nitrogen oxide species resulting from the reaction of NO with oxygen 
or superoxide and are produced when fluxes of NO is high. In general the direct types 
of reactions may be represented as regulatory and/or anti-inflammatory, and the 
indirect types prevail during active inflammation. Thus, to determine the toxic or 
protective roles of NO in biological systems one should consider the relative rates of 
its production, its location, rates of reaction with reactive oxygen species and the 
presence of antioxidants and tissue mediators (Grisham et al., 1999; Freeman et al., 
1995)
1.5.3 Reactive nitrogen species in immunology
The antimicrobial functions of NO have been evident from the inhibitory role of 
macrophage iNOS-derived NO to invading microbes. Macrophage-derived RNS are 
likely to inhibit microbes in a manner that is similar to the mechanisms by which 
RNS inhibit mammalian target cells. Reactive nitrogen species have been shown to 
modify DNA, proteins, and lipids, as well as exert indirect effect on microbes by 
modulating immune responses or other host cell functions (Nathan and Hibbs, 1991; 
Brunelli et al., 1995; Nathan and Shiloh, 2000).
Secondary reactions of reactive oxygen species (ROS), which are produced by all 
aerobic cells, with RNS potentiate the antimicrobial reactivity of RNS (Zhu et al., 
1992). Since their interaction results in the production of a variety of antimicrobial 
molecular species, such as, peroxynitrite ONOO-, which is a potent oxidant as well as 
nitrating and hydroxylating agent. Peroxynitrite have greater cytotoxic potential than
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NO or O2 alone (Fang, 1997). However, RNS cannot discriminate the genomic source 
of their chemical targets.
Reactive nitrogen species are critical in host defence not only because they can inhibit 
pathogens, but also because they are immunoregulatory. They can inhibit G proteins, 
activate or inhibit kinases, caspases, metalloproteases, transcription factors, and DNA 
methyltransferase, inhibit lymphocyte proliferation, alter cytokine and prostaglandin 
production, and either cause or prevent apoptosis of host cells (Nathan and Shiloh, 
2000).
1.5.4 Modulation of nitric oxide synthase activity
The iNOS gene is predominantly regulated at the level of transcription by synergistic 
combinations of pro-inflammatory cytokines and bacterial cell wall product notably 
LPS (Xie and Nathan, 1994; Robbins et al., 1994; Tayler et al., 1998). Sequence 
analysis of the 5’-flanking region of iNOS promoter revealed consensus sequences 
that are implicated in cytokine-modulated gene expression, namely, transcriptional 
factor, nuclear factor- kB  (N F -kB ).
NF- kB  is a heterodimer of proteins of the c-REL family of transcription factors 
which are constitutively expressed and retained in the cytoplasm, associated with an 
inhibitory protein known as inhibitory kB  (IkB ) . Activated NF- kB  complexes are 
translocated to the nucleus in response to mitogens, cytokines and LPS of Gram- 
negative bacteria. Activation of NF- kB  requires phosphorylation and degradation of 























Fig. 1.10. Schematic diagram of nuclear factor -kB (NF- kB) leading to gene 
transcription in lung epithelial cells. Activation of NF- kB involves the 
phosphorylation, ubiquitination and subsequent proteolytic degradation of 
the inhibitor of NF- kB (IkB). Free NF- kB then translocates into the nucleus 
and binds to its consensus sites. The activation of NF- kB leads to the co­




murine iNOS, whereas, it appears to be less important in the regulation of human 
gene (Chu et al., 1998). Human iNOS regulation appears to require IFN-y and the 
activation of the NF-kB and activators of transcription (STAT)-l (Guo et al., 1997) 
Interleukin (IL)-13 and the related cytokines IL-4 and IL-10 are regulatory cytokines 
secreted by activated T helper (Th) 2 cells. They have been proposed to induce 
variety of immunomodulatory functions on a wide range of cell types, including 
macrophages, natural killer (NK) cells, fibroblasts, airway smooth muscle cells, 
endothelial cells and eosinophils (Brombacher, 2000). Interleukin-13 has been shown 
to display anti-inflammatory properties that include modulation of monocyte and B 
cell function, suppression of cytotoxicity mediated by monocyte production of pro- 
inflammatory cytokines including TNF-a, IL -la and IL-lp, IL-6 , IL-8 , and 
macrophage inflammatory protein (M lP)-la (Zurawski and Dervies, 1994). IL-13 can 
modulate IL- 8  and inhibit iNOS and cyclooxygenase-2 (COX-2) expression in the 
human colon epithelial cell line, HT-29 (Kolios et al., 1996 and et al., 1998). In the 
lung, IL-13 and IL-10, but not IL-4, were identified as endogenous cytokines that 
exhibit an anti-inflammatory effect via the suppression of NF-kB during an acute 
inflammatory lung injury. Inhibiting the endogenous IL-13 and IL-10 with antibodies 
enhanced NF-kB activation and caused an increase in intrapulmonary production of 
TNF-a, which was associated with increased accumulation of neutrophils and 
increased leakage of albumin (Lentsch et al., 1999).
Several groups have shown that during pro-inflammatory cytokine or LPS treatment, 
IL-4, IL-10 and IL-13 acted as negative modulator of NO synthesis. However, their 
inhibitory effects are tissue specific (Saura et al., 1996; Wright et al., 1997; Diaz-
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Guerra et al., 1999; Rutschman et al., 2001). In the human pulmonary epithelial cell 
line A549 and the human colon epithelial cell line HT-29, IL-13 and IL-4, but not IL- 
10, inhibited transcriptional iNOS up-regulation by pro-inflammatory cytokines 
(Berkman et al., 1996; Wright et al., 1997). Moreover, the inhibitory pathways of 
iNOS in activated HT-29 cells, renal mesangial cells and murine macrophages were 
via up-regulation of IkB levels and this effect was attributed to the action of 
phosphatidylinositol 3-kinase (Donaldson et al., 1996; Wright et al., 1997; Diaz- 
Guerrae/a/., 1999)
1.5.5 Nitric oxide synthases and CF
Despite the inflammatory nature of CF lung disease, levels of exhaled NO have been 
reported as either normal or low when compared with healthy non-smoking controls 
(Kelley and Drumm, 1998). Grasemann et al., (1997) observed a significant reduction 
in levels of NO from CF patients when compared with nonsmoking controls. 
Moreover, another study showed that exhaled and nasal NO is reduced in adult 
patients with CF, and there was no correlation between exhaled and nasal NO and 
genotype, or with infection status (Thomas et al., 2000). The reason behind decreased 
concentrations of expired NO in CF is still controversial. Kelley and Drumm (1998) 
demonstrated a lack of iNOS expression in murine CF respiratory epithelium, and CF 
human trachea. They also correlated low activity of iNOS to sodium hyperabsorption 
and susceptibility to bacterial infection. More recent studies have hypothesized that 
nNOS makes an important contribution to expired NO. Animals with non-functional 
nNOS gene had 40% less NO compared with wild-type mice (De Sanctis et al., 1997).
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Neuronal NOS-derived NO is the main neurotransmitter of human nonadrenergic, 
noncholinergic (NANC) nerves that are involved in human bronchomotor control. It 
was found that the inducible NANC system is abnormal in CF, which may lead to 
airway obstruction and alteration of pulmonary functions (Belvisi et al., 1995). 
Measuring NO levels in expired air may not be a useful clinical indicator of CF. 
Since sputum NO2 /NO3 analysis demonstrated an elevated concentration from CF 
patient with acute pulmonary exacerbation compared with stable CF patients and 
normal control objects. This finding suggests that NOS is activated in CF with acute 
exacerbations and NO is trapped in the airway secretions (Linnane et al., 1998). 
Other studies explained the low NO that it combines with superoxide anion produced 
by neutrophils to produce peroxynitrite that can form nitrotyrosine or decompose to 
nitrate (Jones et al., 1998; Robbins et al., 2000).
1.6 Cell mediated immunity of the respiratory tract
1.6.1 Alveolar macrophages
Alveolar macrophages (AM) constitute the first line of phagocytic defence against 
infectious agents that evade the mechanical defences. They lie on the alveolar walls 
and gain access to the gas-exchanging airways. These cells have important phagocytic, 
microbicidal, and secretory functions that are essential to lung immunity via initiating 
inflammatory and immune responses. Alveolar macrophages phagocytose microbial 
challengers to maintain sterility of the alveolar space, which lack mucociliary 
properties. Alveolar macrophages are capable of generating numerous mediators that 
orchestrate the recruitment of large numbers of neurophils, or polymorphonuclear
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leukocytes (PMN), from the pulmonary vasculature into the alveolar space. The 
recruitment of neutrophils supports the overall phagocytic capacity leading to 
complete eradication of invaders (Zhang et al., 2000). Alveolar macrophages 
encounter multiple chemoattractant signals that can potentially guide their path. These 
AM-derived substances include complement, arachidonic acid metabolites such as 
leukotriene B4, chemotactic peptides such as IL-8 , and macrophage inflammatory 
protein (MIP)-2, and other related chemokines (Sanchez-Madrid and Del Pozo, 1999). 
In CF it is increasingly recognized that neutrophils-dominate the lower respiratory 
tract, and yet bacteria are not eradicated. Accordingly, more active neutrophils are 
recruited but efficient phagocytosis and lysis of P. aeruginosa still does not take place. 
High concentrations of elastase are released from the short-lived phagocytosis which 
inactivate opsonins and their cognate receptors on the surface of viable phagocytosis, 
by proteolysis. This may lead into a repetitive vicious cycle of fooled self-destructive 
host-defence which causes an extensive brochiectasis, destructive emphysema and 
fibrosis of pulmonary tissue (Tummler and Kiewitz, 1999).
1.6.1.1 Production of reactive oxygen species
At the onset of phagocytosis stimulated PMLs and AMs undergo what is termed 
respiratory burst or oxidative burst. It is a coordinated sequence of biochemical 
reactions characterized by an accelerated O2 consumption to correspond to the high 
rate of oxidative phosphorylation, followed by the one-electron reduction of oxygen 
to superoxide anion (O2’ ) using NADPH or NADH as the electron donor and 
catalysed by a NAD(P)H oxidase (Fig. 1.11).
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NADPH + 2 0 2 _________________ ». NADP+ + H+ + 2 0 2‘"
Superoxide anion (O2* ~ ) is relatively unstable, with a half-life of only milliseconds. 
Because it is charged it does not cross the membrane vesicle that contains the 
engulfed pathogen. However, it will react with proteins that contain transition metal 
prosthetic groups, such as haem moieties or iron-sulfur clusters leading to protein 
damage or protein/enzyme inactivation. Most of the O2* ’generated in vivo undergoes 
a nonenzymatic or superoxide dismutase (SOD)-catalyzed reaction resulting in 
hydrogen peroxide (H2O2) (Repine et al., 1997).
2 0 2’~+ 2H+ —► H20 2 + 0 2
Hydrogen peroxide (H2O2) can be oxidized by neutrophil-specific peroxidase (MPO), 
as well as eosinophil-specific peroxidase (EPO) in the presence of a halide 
cosubstrate, to form a potent oxidant hypohalous acid (HOX) and other reactive 
halogenated species.
h 2o 2 + x " + h + -----► HOX + H2O
Much of the toxic effect of O2* ~ and H2O2 in vivo is due to formation of hydroxyl 
radical (*OH) in a series of reactions catalyzed by transition metal ions. The Haber- 
Weiss reaction is an iron-catalyzed reaction in which ferric ion (Fe3+) is reduced to
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ferrous ion (Fe2+), followed by the Fenton reaction in which Fe2+ catalyses the 
transformation of H2O2 into hydroxyl radical ’OH.
0 2 *" + F e3+ ^  Fe2+ + O 2 Haber-Weiss reaction
Fe2+ + H2O2 —► Fe3+ + *0H' + ’OH Fenton reaction
An alternative pathway for (*0H) production in vivo may involve the MPO and EPO. 
In the presence halides at physiological concentrations, MPO produces hypochlorous 
acid (H0C1), EPO produces hypobromous acid (HOBr) which can result in the 
production of *0H in the presence O2* (Comhairand Erzurum, 2002).
Hydroxyl radicals can react with different molecules including proteins, DNA and 
lipids. When the cellular and anatomic sites of production of O2" and NO are the 
same they react together to produce peroxynitrite ONOO" (Fig. 1.11). Peroxynitrite is 
a strong oxidant capable of reacting by multiple oxidative mechanisms (van der Vliet 
and Cross, 2000).
0 2’" + *NO_______► ONOO"
ONOO" + H+ ------- ► ONOOH
Peroxynitrous acid ONOOH spontaneously decomposes to nitrate (NO3") via the 
intermediate formation of a nitrogen dioxide (NO2) and hydroxyl radical. In vivo, the
reactivity of ONOO" is quite wide. Its half-life is approximately 1 second in
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phosphate buffer at 37°C and pH 7.4, which allows it to diffuse for up to several cell 
diameters from its site of formation (Zhu et al., 1992).
As stated earlier, peroxynitrite is emerging as a major product among RNS and ROS, 
not only toward microorganisms but also towards mammalian cells. ONOCT is also a 
nitrating agent, since it can react with tyrosine residues in proteins yielding 3- 
nitrotyrosine, which has been detected in several lung diseases, including acute lung 
injury, adult respiratory distress syndrome (ARDS), asthma, idiopathic pulmonary 
fibrosis and CF. This nitration pathway would inhibit tyrosine phosphorylation 
(Grisham et al., 1999). The electron transfer onto tyrosine residues deforms protein 
structure and consequently alters functions (van der Vliet and Cross, 2000). In 
addition, the structure of nitrotyrosine resembles dinitrophenol, which is a strongly 
antigenic compound used for making haptens. Endogenous nitration may therefore 
initiate autoimmune processes (van der Vliet et al., 1999).
The deleterious actions of ONOCT can also be mediated by interactions with several 
other biological targets, including haem proteins such as cyclooxygenase and 
lipoxygenase, or nucleophilic targets in protein or DNA. Modification of DNA bases 
by NO-derived oxidants (purine deamination, guanine nitration) has been implicated 
in NO-associated mutagenesis (van der Vliet and Cross, 2000). However, ONOO” 
can react rapidly with low molecular weight thiols, such as glutathione (GSH) or 
cysteine forming S-nitrosothiols which have been proposed as a mechanism either of 
enzyme regulation or NO transport, and may provide a unique signaling mechanism 
induced by nitrosative stress (van der Vliet et al., 1999; van der Vliet and Cross, 
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is methionine (Met). Oxidation of Met residues may alter the biological activity of 
specific proteins such as ribosomal protein L I2 , a - 1 -proteinase inhibitor, calmodulin, 
and the voltage-gated K+channel (St.John et al., 2001).
1.6.2 Cellular antioxidant defence
To minimise oxidant damage to biological molecules, the human lung has anti 
oxidant activity products that can be acted upon by other antioxidants. Normally, 
ROS and RNS are removed rapidly before they cause cell dysfunction and cell death. 
There are a number of primary antioxidant enzymes in the lung including catalase, 
superoxide dismutase (SOD) and a glutathione system (GSH). SOD is an ubiquitous 
enzyme with an essential function in protecting aerobic cells against oxidative stress. 
It catalyses O2* " to H2O2 . Catalase is most effective in the presence of high 
concentrations of small molecules such as H2O2 and methyl or ethylperoxide. In the 
presence of low concentrations of either H2O2 or other peroxides, the glutathione 
system plays a critical role (Comhair and Erzurum, 2002). In addition, nonenzymatic 
antioxidants called ‘scavengers’ have a suicide role by reacting directly with 
oxidizing agents. These include vitaminE (a-tocopherol), p-carotene, uric acid, 
glucose, bilirubin, taurine, albumine, and cytseine and cysteamine (Comhair and 
Erzurum, 2002).
In vitro studies suggest that mutation in CFTR may impair lung antioxidant defences 
making the CF lung more susceptible to oxidative stress (Velsor et al., 2001).
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1.7 Bacterial infection of the respiratory tract of CF
Chronic microbial colonization of the major airways is the major source of morbidity 
and mortality in CF patients. As described earlier, respiratory infection is not the 
result of altered pulmonary development since lungs of neonates with CF are 
structurally normal as well as sterile. Rather, inactivation of a first line of defence 
related directly or indirectly to mutations in CFTR, allows colonization of the 
respiratory tract with characteristic bacterial species. Initially, Staphylococcus aureus 
and non-typable Haemophilus influenzae are frequently isolated from young patients 
with CF. However, there are no compelling data to indicate that either S. aureus or H. 
influenzae contribute to lung function decline in CF except on rare occasions when 
they cause pneumonia or emphysema (Pier, 2000). These infections typically make 
the respiratory tract susceptible to the opportunistic pathogen Pseudomonas 
aeruginosa, which is the major problem for most CF patients (Tummler and Kiewitz, 
1999). After prolonged infection with P. aeruginosa, which usually become mucoid, 
CF patients become superinfected with organisms such as Burkholderia cepacia, 
Aspergillus fumigatus and atypical Mycobacterium (Pier, 2000). Burkholderia 
cepacia has been recognized as a major pathogen in patients with CF since the late 
1970s (Henrey et al., 2001). The inherent resistance of B. cepacia to multiple 
antibiotics makes eradication of this pathogen from the lungs of infected individuals 
especially difficult (Tummler and Kiewitz, 1999). High dose and long term 




Recent work has demonstrated strong evidence that P. aeruginosa cells exist as a 
biofilm in CF lung (Singh et al., 2000). Biofilms are sessile microbial communities. 
They are initiated by surface attachment of individual planktonic bacteria, followed 
by cell-cell interactions that facilitate development into a matrix of hydrated polymers 
of an elaborate three-dimensional structure (Costerton et al., 1995; Watnick and 
Kolter, 2000). The biofilm mode of growth allows bacterial cells to withstand host 
immune responses, and exhibit increased resistance to antibiotics and biocides when 
compared with the same cells growing in liquid culture (Xu et al., 2000). 
Pseudomonas aeruginosa utilizes signal molecules called N-acylhomoserine lactones 
(AHLs) to monitor its population size in a process called quorum sensing (QS) (Van 
Delden and Iglewski, 1998; Williams et al., 2000; De Kievit and Iglewski, 2000). In 
addition AHLs are used by P. aeruginosa for cell-cell communication (Davies et al.,
1998) and recently it was demonstrated that mixed biofilms of P. aeruginosa and B. 
cepacia in the lung of CF employ AHL-dependent QS systems to link biofilm 
formation with the expression of pathogenic traits (McKenney et al., 1995; 
Geisenberger et al., 2000; Riedel et al., 2001). Communication by AHLs may be of 
significant importance for the virulence of this association (Davies et al., 1998) and 
may also promote the chronic inflammation in the CF lung (Favre-Bonte et al., 2002).
1.7.1 Burkholderia cepacia complex
Burkholderia cepacia complex (Bcc) describes a diverse group of bacteria whose 
natural habitats include soil, water, and the rhizosphere of plants. It is an aerobic 
Gram-negative motile bacillus that formerly belonged to the genus Pseudomonas. B.
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cepacia complex possess an uncommon genome topology of three replicons, which 
total approximately 7.6 Mb of DNA with a G+C content of approximately 68-70% 
(Lessie et al., 1996). This highly plastic genome provides Burkholderia with high 
adaptive capacity to survive in extreme environments (Zanetti et al., 2000).
Burkholderia cepacia complex is divided into nine genomic species or genomovars 
(Govan, 2002), which are phenotypically similar but genetically distinct groups of 
strains. They have been classified according to DNA-DNA hybridization, whole cell 
protein pattern similarity and phenotypic markers. Knowing that all strains of the Bcc 
were clinical isolates from CF patients, however, strains of genomovar II (B. 
multivorans) and III account for over 90% of clinical isolates (Keig et al., 2001; 
Govan, 2002) and can be further divided into two groups on the basis of recA 
sequence (Parson et a l, 2001). It has been recently demonstrated that clinical isolates 
from Canada are from genomovar III, the most highly transmissible strains with a 
higher mortality rate than other members of the complex, while genomovar II appears 
to be nontransmissible (except between siblings) and associated with relatively 
benign clinical outcomes (Speert et al., 2002).
Interest in these highly versatile microbes stems primarily from their importance as a 
phytopathogen causing soft rot in onion bulbs, as biocontrol agents in the 
bioremediation of toxic agents (Melnikov et al., 2000) and as efficient biopesticides 
(Govan and Vandamme, 1998; Govan, 2000). Whilst B. cepacia is an environmental 
pathogen, there is clear evidence of person-to-person spread of various B. cepacia 
epidemic strains in CF populations both within and outside hospitals. Molecular 
typing of isolates from patients and contacts demonstrated that transmission is strain-
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specific (Caims et al., 2001). It has been found that clinical isolates can survive for 
long periods in respiratory droplets on environmental surfaces typically found in CF 
clinics (Drabick et al., 1996). In addition it was proposed that Acanthamoeba and 
other free-living amoeba can serve as a reservoir for B. cepacia and may serve as a 
vehicle for transmission of B. cepacia from patient to patient (Marolda et al., 1999). 
According to data from North America and Europe, the prevalence of B. cepacia in 
CF clinics is approximately 3-8%, with occasional epidemics increasing the 
prevalence to around 30% (Fitzgerald et al., 2001). In United Kingdom CF centres, B. 
cepacia has been isolated from up to 40% of CF patients (Hughes et al., 1997).
1.7.1.1 Pathogenesis of B. cepacia in CF
For the past two decades B. cepacia strains have emerged as human opportunistic 
pathogens. The most frequently reported site of infection in human is the lower 
respiratory tract of patients with CF (Govan and Deretic, 1996) or chronic 
granulomatous disease (CGD), which is a rare genetic disorder resulting in a defect in 
oxidative killing mechanism of phagocytic cells (Speert et al., 1994). In CF there are 
two main cell types encountered by B. cepacia infection, they are respiratory epithelial 
cells and pulmonary macrophages where organisms can persist and survive (Bums et 
al., 1996; Tipper et al., 1998; Saini et al., 1999; Martin and Mohr, 2000). In addition 
B. cepacia organisms have been harvested from tracheal epithelial cells at the time of 
autopsy from a CF patients (Bums et al., 1992).
Infection with B. cepacia in CF is usually acquired late in the course of the disease 
and can lead not only to a decline in respiratory function, due to onset of necrotizing
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pneumonia, but also to an acute systemic infection, such as bacteremia or septicemia 
(Tablan et al., 1985). The rapid clinical decline due to B. cepacia colonization is 
known as cepacia syndrome, which leads to mortality in approximately 20 to 35% of 
chronically colonized individuals (Isles et al., 1984). Furthermore, infection with B. 
cepacia reduces the life expectancy of CF patients by 50%, from 30 to 15 years 
(Hutchison and Govan, 1999).
Although fatal pulmonary infections in CF patients are associated with B. cepacia, 
the pathogenic mechanisms and virulence determinants are only beginning to be 
elucidated. Over 80% of CF patients are typically colonized with P. aeruginosa. 
Indeed, it has been suggested that P. aeruginosa produces an extracellular factor, 
which facilitates the attachment of B. cepacia (Riedel et al., 2001). B. cepacia 
appears to establish colonization by adhering first to respiratory tract epithelial cells 
(Chiu et al., 2001). Attachment occurs via pili (including the cbl pilus) that bind 
specifically to cytokeratin 13 of respiratory squamous epithelial cells (Sajjan et al., 
1995), although attachment to non-squamous epithelial cells has been reported (Bums 
et al., 1996). In vitro studies recently indicated that flagellum-mediated motility of B. 
cepacia, may facilitate its penetration of host epithelial barriers, contributing to 
establishment of infection and systemic spread of the organism (Tomich et al., 2002). 
Once within the host, B. cepacia could produce a number of potential virulence 
factors, including proteases (Kooi et al., 1994), lipases (Jorgensen et al., 1991), 
hemolysins (Nakazawa et al., 1987), siderophores (Darling et al., 1998), catalase, 
superoxide dismutase (SOD) (Lefebre and Volvano, 2001), melanin like pigment 
(Zughaier et al., 1999a) and lipopolysaccharide (Zughaier et al., 1999b; Shimomura
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et al., 2001) which have been suggested to cause pathological changes in the CF lung. 
However, little is known about the pathophysiology of B. cepacia in CF. Recently a 
murine pulmonary model of sustained infection was developed to understand better 
the pathogenicity among genomovars of B. cepacia as well as to demonstrate 
differences in virulence among genomovars (Chu et al., 2002). Colonization of CF 
patients with B. cepacia can result in three clinical outcomes: asymptomatic carriage, 
slow and continuous decline in lung function, or for approximately 20% of the 
patients, severe lung dysfunction and fatal pneumonia, the so- called ‘cepacia 
syndrome’ (Isles et al., 1984). Epidemiological studies have demonstrated that 
patients colonized with the identical strain of B. cepacia may respond differently, 
suggesting that cepacia syndrome may not be solely dependent on the type of strain 
colonization but also to underlying host factors to colonization (Palffeyman et al.,
1997). Once colonization with this pathogen is established it is rarely, if ever, be 
eradicated. A potential explanation is its ability to invade and survive within the 
respiratory epithelial cells (Bums et al., 1996) and phagocytes (Saini et al., 1999). 
Intracellular growth in macrophages is an important way in which B. cepacia can 
avoid antibiotic exposure and evade the immune response (Tummler and Kiewitz,
1999). Survival within professional phagocytes suggests that B. cepacia can escape 
the bactericidal mechanisms employed by these cells. Burkholderia cepacia 
demonstrate resistance to non-oxidative killing pathways mediated by cataionic 
peptides of neutrophils, such as (3-defensin, as they are able to survive in the presence 
of neutrophils from CGD (Speert et al., 1994). In addition B. cepacia is resistant to 
p-defensin-like activity of airway epithelial cells (Baird et al., 1999). Therefore, any
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killing o f B. cepacia by phagocytes must be mediated by ROS. However, Saini and 
colleagues (1999) demonstrated survival of B. cepacia in a macrophages cell line, in 
the presence of cell activation and oxidative burst, suggesting that bacterial resistance 
to oxidative damage may explain in part, their persistence and ability to elicit a 
continual inflammatory response (Saini et al., 1999). Martin and Mohr, (2000) 
established a macrophage model of invasion and intracellular survival for B. cepacia, 
which was found enclosed in a membrane-bound vacuole (Martin and Mohr, 2000). It 
has recently been shown that the melanin-like pigment produced by epidemic strains 
of B. cepacia is able to scavenge superoxide anions, which may allow it to survive the 
respiratory burst response of phagocytic cells (Zughaier et al., 1999). Furthermore, a 
recent study showed that NO acts synergistically with ROS to kill B. cepacia in vitro 
(Smith et al., 1999). Since iNOS activity may be absent from cells in CF patients 
(Kelley and Drumnn 1998), this may explain the survival of B. cepacia in the CF 
lung. However, intracellular survival does not appear to be a function common to all 
strains of B. cepacia CF (Martin and Mohr, 2000). Differences in the ability to 
survive intracellularly may have implications for the varied disease progression 




Increasing susceptibility of CF patients to bacterial infection may be attributed to two main 
factors. First, underlying host factors that permit initial colonization of the CF lung by 
pathogenic bacteria, despite a vigorous host immune response. Secondly, the ability of certain 
opportunistic bacteria to persist and survive intracellularly in human cells. The aims of this 
study were:
• To investigate the intracellular signaling mechanisms involved in nitric oxide 
production in human pulmonary epithelial cells by pro-inflammatory cytokines.
• To determine if substrate availability may play a role in controlling the rate of nitric 
oxide production.
• To determine the susceptibility of strains of B. cepacia complex to hydrogen peroxide 
at two different stages of life cycle (mid-log and early stationary) when grown as 
planktonic and biofilm forms.
• To determine catalase activity in the some strains B. cepacia complex when growing 
as planktonic and biofilm.
• To isolate, clone and sequence the catalase gene (katE) of B. cepacia J2315 that 





AH reagents were supplied by Sigma Chemical Co. (Poole, Dorset) unless otherwise stated. 
Electrophoresis-grade agarose, EDTA, ethanol, isopropanol, MgCE and MnCE were supplied 
by Merck (Poole, Dorset). All media and reagents used for cell culture were supplied by 
Gibco BRL (Paisley, Scotland).
2.2 Cell Culture
A549 cells, obtained from American Type Culture Collection (ECACC), were routinely 
cultured in 80cm2 tissue culture flasks in Dulbecco’s modified Eagles medium (DMEM) 
supplemented with penicillin (10 units/ml); streptomycin (10 pg/ml), fungizone (0.5 pg/ml) 
and 10% (v/v) heat inactivated foetal bovine serum (FBS), which will be referred as complete 
medium. Cultures were maintained at 37°C in an atmosphere of 5% CO2 . Cultures were fed 
every three days. Confluent monolayers were used to subculture cells where they were 
washed three times with Dulbecco’s phosphate-buffered saline (DPBS) (without Ca2+ and 
Mg2+). Then cells were incubated approximately for 5 min, until cells had detached from the 
flask, at 37°C with 1 ml Trypsin-EDTA mixture of 0.05% (w/v) Trypsin and 0.02% (w/v) 
EDTA. So as to inhibit the action of Trypsin-EDTA 25 ml complete medium were added to 
stop the action of Trypsin-EDTA after complete detachment. The cell suspension was 
centrifuged at 2000 * g for 5 minutes. The cells pellet was resuspended in 5 ml complete
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medium and cell counting and viability were checked in a Naubauer haemocytometer after 
mixing with trypan blue (0.4% w/v in PBS). Cells were seeded at 105/ml of DMEM complete 
medium into 80 cm2 tissue culture flasks or into 6 well plates for experimental procedures.
For storage, cells were resuspended at 4 x 106 cells/ml of freeze medium (10% (v/v) DMSO, 
40% (v/v) FBS, and 50% (v/v) DMEM). The cell suspension was transferred to cryotubes at 1 
ml/tube. Cells were then cooled gradually in the vapor phase overnight and then finally were 
stored in liquid nitrogen tanks. For resuscitation of cells from liquid nitrogen, cells from one 
cryotube were rapidly defrosted at 37°C in water bath, washed and resuspended in DMEM 
complete medium and then seeded into 80cm2 tissue culture flasks in DMEM complete 
medium.
2.2.1 Experimental protocol
For all experimental procedures A549 cells were grown until confluent. Prior to experiments, 
monolayers were washed and cultured in FBS-free DMEM for 24 hours. Growth arrested 
cultures were treated with fresh FBS-free medium and stimulated with the appropriate doses 
of either drugs, cytokines or vehicle controls for the time described. Supernatants were 
collected, centrifuged to remove cellular debris and stored at -70°C until assayed for 
extracellular nitrite (see below).
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2.2.2 Fluorometric nitrite assay
Nitric oxide (NO) production by A549 cells was determined by measuring the stable end 
product nitrite in the cell culture supernatants by fluorometric assay. It was based upon the 
reaction of nitrite, under acidic conditions, with 2,3-diaminonaphthalene (DAN) (Lancaster 
Synthesis Ltd.) to result in the formation of the fluorescent product l-(H)-naphthotrizole. The 
assay was modified from the method of Miscko et al., (1993) for use on a Photon Technology 
International (PTI) spectrofluorimeter. As specified by Misko et al., (1993), an excitation 
wavelength of 365 nm and an emission wavelength of 405 nm were used. A standard curve of 
sodium nitrite in FBS-free DMEM ranging from 20 nM to 3.0 pM was prepared. The reaction 
was initiated by mixing 1 ml standard or culture supernatant with 100 pi of freshly prepared 
DAN reagent (50 pg/ml DAN in 0.62 M HC1) in disposable cuvettes. The mixture was 
incubated at room temperature in the dark for 10 minutes and the reaction was stopped by the 
addition of 1 ml of 0.28 N NaOH. The samples were read in spectrofluorimeter and nitrite 
concentration was calculated by reference to the standard.
2.2.3 Cell lysis and sample preparation
After each specified treatment of confluent monolayers of A549 cells in 6-well plates culture, 
stimulations were determined at the appropriate times by aspiration of supernatants. The cells 
were rinsed with ice-cold Dulbecco’s phosphate-buffered saline (DPBS) twice. Three hundred 
microliter of ice-cold lysis buffer were added to each sample containing 50 mM tris 
(hydroxymethyl)aminomethane (Tris-HCl)(pH 7.5), 0.1 mM EDTA, 1 mM dithiothreitol,
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1 pg/ml leupeptin, 1 pg/ml aprotinin, and 0.1 mM phenylmethylsulfonyl fluoride (Chang et 
al., 1998). Cells were disrupted using a cell scraper and the resulting lysates transferred to 
microfuge tubes, which were incubated at 4°C for 15 minutes. Cells were lysed by sonication 
at a frequency of 20 KHz (Soniprep 150) for 30 seconds (10 second/cycle) in an ice water 
bath. Finally, lysates were centrifuged at 12000 x g for 10 minutes at 4°C. Supernatants were 
transferred to fresh 1.5 ml microfuge tubes and kept on ice until assayed.
2.2.4 Arginase assay
Arginase activity in cell lysates was measured from the rate of urea production using the 
method descried by Corraliza et al., (1994). Fifty micoliters of cell lysate were added into 
50 |j.1 Tris-HCl (50 mM; pH 7.5) containing 10 mM MnCE. A549 arginase was then activated 
by heating this mixture at 55-60°C for 10 minutes. The hydrolysis of L-arginine by arginase, 
was carried out by incubating the mixture containing activated arginase with 50 pi of L- 
arginine (0.5 M; pH 9.7) at 37°C for 1 hour and was stopped by adding 200 pi of acid solution 
mixture (H2SO4H3PO4H2O = 1:3:7). For colorimetric determination of urea, a- 
isonitrosopropiophenone (25 pi, 9% in absolute ethanol) was added, and the mixture was 
heated at 100°C for 45 minutes. After the mixture was incubated in the dark for 10 minutes at 
room temperature. The urea concentration was determined spectrophotometrically by the 
absorbance at 540 nm measured with a Dynatech MR5000 microplate reader, using 200 pi 
aliquots in non-sterile microtiter plate. A standard curve was prepared with increasing 
amounts of urea between 0.1 and 0.9 pmol.
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2.3 Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed in Tables 2.1. B. cepacia and E. 
coli cultures were routinely grown in Luria-Bertani (LB) medium (Bacto-tryptone 10 g/1, 
yeast extract 5g/l, NaCl 5 g/1, pH 7.5) at 37°C with aeration (200 rpm), or on agar plates 
containing LB medium supplemented with 1.5% Bacto-agar and incubated at 37°C for the 
time required. The medium was supplemented with ampicillin 100 pg/ml as required.
Description Source/reference
Burkholderia cepacia J2315 Genomovar III Smith et al., 1999
Burkholderia cepacia J2552 Genomovar I Smith et al., 1999
Burkholderia cepacia JL27 Genomovar III Smith et al., 1999
Burkholderia cepacia JL32 Genomovar III S m ith s  al., 1999
Escherichia coli JM109 Ampr Promega
Table 2.1. List of bacterial stains.
2.3.1 M aintenance of strains
Strains were stored at -70°C in LB with 20% (v/v) glycerol. Bacteria were revived by 
streaking aliquots on appropriate media and incubating at 37°C. Short-term working stocks 
were maintained at 4°C on solid media. B. cepacia strains were kept at room temperature.
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2.3.2 Measurement of optical density
Growth of bacterial cultures was routinely monitored by measuring optical density at 470 nm 
in a Spectronic 601 spectrophotometer (Milton Roy).
2.3.3 Inoculation and growth of planktonic cultures
Cultures were grown at 37°C with aeration (200 rpm) in baffled, 250 ml conical flasks. 
Overnight starter cultures were grown in 25 ml volumes and all other cultures were grown in 
25 ml or 50 ml volumes. A standard inoculation procedure was followed; overnight cultures 
were diluted in a ratio of 1:100 into fresh LB broth.
2.3.4 Inoculation and growth of biofilm cultures
Biofilms were grown on a filter support placed on LB agar plates. Sartorius hydrophobic 
edged membranes (pore size 0.2 pm, 45 mm diameter) (Fisher Scientific) were placed in a 
filter holder (Nalgene) and washed with 5 ml sterile M9 minimal salts solution (Buhler et al.,
1998). Membranes were then placed on the surface of LB agar and prewarmed at 37°C for 1 
hour. Cells from stationary phase culture were diluted to 2 * 107 m l'1 in sterile M9 minimal 
salt solution. An aliquot (50 pi) of the bacterial suspension was dropped onto the centre of the 
membrane and the agar plate/membrane was incubated at 37°C. Filter grown cells were 
harvested by scraping the membrane with a sterile glass spreader, resuspended in 5 ml M9 
minimal salts solution and vortexing to dispense aggregates.
METHODS 50
CHAPTER 2
2.3.5 Bacterial killing assay
Bacterial cultures were grown in LB broth or on filter membranes at 37°C until stationary 
required phase. For planktonic cultures they were harvested by membrane filtration, washed 
and suspended in M9 minimal salt solution to 1 * 109 cfu/ml, while for membrane cultures a 
bacterial suspension of 1 * 109 cfu/ml was prepared directly. Bacterial cells were added to 5
n
mM H2O2 to a final density of 1 x 10 cfu/ml. Samples were removed every 15-minutes 
period for 60 minutes, and put into an inactivation medium comprising catalase 10 OOOU/ml 
in M9 salts solution. A minimum of a 1 in 10 dilution into inactivation medium was 
performed. After appropriate serial dilution in this inactivation medium 10 pi samples were 
inoculated in triplicate on LB agar plates using the Miles and Misera, (1938) method. Colony- 
forming units (cfu) were counted after 48 hours incubation at 37°C, and the logio reduction in 
viability calculated against a non-treatment control.
2.3.6 Detection of bacterial catalase activity
2.3.6.1 Preparation of crude cell extract
Cell extracts were prepared from 30 ml planktonic cultures, which were centrifuged at 7000 x 
g  for 10 minutes at 4°C. Bacterial pellets were washed twice in ice-cold 0.05 M potassium 
phosphate buffer (pH 7.0) and finally resuspended in 1.5 ml 0.05 M potassium phosphate 
buffer (pH 7.0) supplemented with 0.1% dithiothreitol stored on ice. Cells were lysed by 
sonication (Soniprep 150) for a total of 3 minutes (60 second/cycle) in an ice water bath.
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Lysates were centrifuged at 12 000 * g  for 5 minutes at 4°C to sediment cellular debris and 
unbroken cells. Supernatants were stored at -20°C in 50% (v/v) glycerol. Under these 
conditions catalase activity could be preserved for several months.
For the preparation of a crude cell extracts from bacterial biofilms the same procedure was 
used. In order to obtain sufficient cell mass, extracts were prepared after harvesting 6 
inoculated membranes/strain at specific growth points in 30 ml ice-cold 0.05 M potassium 
phosphate buffer (pH 7.0).
2.3.6.2 Enzymatic activity assay
The catalase specific activities of cell lysates were determined using the spectrophotometric 
protocol mentioned by Katsuwon and Anderson, (1992). Catalase activity was monitored by 
following the decomposition of 5 mM H2O2 in 0.05 M potassium phosphate buffer at 240 nm 
at 25°C. An appropriate amount of cell-free extract was added to 650 pi of 5 mM H2O2 in 
0.05 M potassium phosphate buffer in a quartz cuvette, mixed thoroughly, and H2O2 
decomposition monitored for 1 minute. Specific activity was calculated from the following 
equation: Specific activity = AOD24o/min x total reaction volume
e 240 x nig protein
The e 240 is the extinction coefficient = 43.6 M '1. cm"1 for H2O2 .





The estimation of total protein per lysate was based on the Bradford dye-binding procedure 
(Bradford, 1976). A 1 mg/ml solution of bovine serum albumin (BSA) was prepared in 
0.05 M potassium phosphate buffer (pH 7.0) to produce known concentrations of BSA in 1 ml 
of Bio-Rad protein assay (Bio-Rad). Equal volumes of each sample (20 pi) were added to 
1 ml of Bio-Rad protein assay and 200 pi of sample or standard were transferred in duplicate 
to the wells of 96-well microtiter plate. The plate was read at 595 nm on a Dynatech MR5000 
plate reader. The protein concentrations were calculated by linear regression from the 
standard curve.
2.3.6.4 Native polyacrylamide gel electrophoresis (PAGE) to visualize catalase isozyme 
patterns
The native gel electrophoresis method described by Hassett et al., (1999b) was used with 
Bio-Rad Mini Protean II system. Native 4% (w/v) stacking and 7% (w/v) resolving 
polyacrylamide gels were used. The wells were loaded with 10-20 pg of cell-free extract per 
lane after being mixed with high-density sucrose tracking-dye (5 g sucrose, 10 mg 
bromophenol blue, 1.5 ml running buffer and Milli-Q up to 5 ml). A constant current of 20 
mA was applied at 4°C in native PAGE running buffer (25 mM Tris, 192 mM glycine) until 
the tracking dye reached the bottom of the gel.
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After electrophoresis, the gels were stained according to the method previously described by 
Clare et al. (1984). This method involves soaking the gel first in horseradish peroxidase 50 
pg/ml in potassium phosphate buffer (pH7.0) for 45 minutes. Hydrogen peroxide was then 
added to a concentration of 5 mM and soaking continued for 10 minutes. The gels were then 
rapidly rinsed twice with Milli-Q water and finally placed into 0.5 mg/ml of 
diaminobenzidine in potassium phosphate buffer (pH 7.0), until staining was completed.
Reagents 7% Resolving Gel 4% Stacking Gel
40% (w/v) acrylamide:bisacrylamide 
37.5 : 1
3.5 ml 1.33 ml
1 M Tris-HCl, pH 8.8 5.6 ml -
1 M Tris-HCl, pH 6.8 - 1.25 ml
Milli-Q Water 6.1 ml 6.51
10% APS 50 pi 50 pi
TEMED 20 pi 20 pi




2.4.1 Multiple sequence alignment construction
Sequence alignment was undertaken to analyse the degree of conservation of the catalase 
KatE peptide sequence of E. coli, with sequences of other catalase KatE peptides from Gram- 
negative bacteria in the Genbank database. Sequence retrieval was performed using database 
searching at Genbank. A multiple sequence alignment was compared and analyzed using the 
program Clustalx, which is available on the European Bioinformatics Institute (EBI) website 
(http://www.ebi.ac.uk/!. After highlighting regions of high homology between KatE catalase 
peptide sequences o f E. coli and P. aeruginosa, degenerate primers were designed using 
P. aeruginosa codon usage data (West and Iglewski, 1988) and used for PCR amplification of 
B. cepacia chromosomal DNA.
2.4.2 Small scale chromosomal extraction
Small-scale chromosome extraction was carried out using the Genomic kit from Helena 
Biosciences (Sunderland, UK), in accordance with the manufacturer’s instructions.
2.4.3 Spectrophotometric determination of nucleic acid concentration
Quantitation of DNA was performed using a GeneQuant II spectrophotometer (Pharmacia 
Biotech, St. Albans, Herts). Then nucleic acid concentration was determined from absorbance 




2.4.4 Polymerase chain reaction (PCR)
Reaction mixtures of a total volume of 100 jul were prepared with 200 pM each of 
deoxynucleotides, 2 mM magnesium chloride, 10 pM primers and 10 pi 10 x reaction buffer 
(all supplied by Gibco BRL, Paisley, Scotland). Template DNA (50 pg of genomic DNA, or 
10 ng plasmid DNA) was added and 1 unit of Platinum Taq DNA polymerase (Gibco BRL) 
used in each reaction. Each reaction was overlaid with 59 pi of mineral oil to prevent 
evaporation. PCR was carried out in a Crocodile II thermocycler (Appligene, Watford, UK) 
with an initial denaturation step at 94°C for 2 minutes, followed by 30 cycles of denaturation 
(94°C for 1 minute), annealing (55°C for 1 minutes) and extension (72°C, 1 minute per 1 kb). 
The reaction was terminated with an extended elongation step (72°C for 5 minutes). PCR 
products were analyzed by horizontal agarose gel electrophoresis.
2.4.5 Horizontal agarose gel electrophoresis
Horizontal agarose gel electrophoresis was used to resolve DNA fragments between 
approximately 100 bp and 10,000 bp. Electrophoresis was performed in a Bio-Rad DNA 
subcells (Bio-Rad Richmond, Ca.). The running buffer comprised lx  TBE 
(Tris/borate/EDTA). Electrophoresis-grade agarose (0.7% to 1.5%) was dissolved in an 
appropriate volume of 1 * TBE buffer at high temperature in a microwave oven. The solution 
was allowed to cool to approximately 60°C before being poured into a casting tray and left to 
set. The gel tray was mounted in an electrophoresis tank and submersed in 1 x TBE.
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DNA samples were mixed with 6* loading buffer (10 mM Tris, 25% glycerol, 0.25% 
bromophenol blue, 0.5% SDS, 0.05 M EDTA) in a 5:1 a ratio and loaded onto the gel. 
Appropriate DNA standards were also loaded (Helena BioSciences). Generally, a 1 kb ladder 
was used for DNA samples >1 kb, and a lOObp ladder for samples < 1 kb. Electrophoresis 
was carried out at 80 V for 90 minutes or until full separation of bands, after which the gel 
was soaked in an ethidium bromide (0.5 pg/ml) solution 30 minutes. The stained gel was 
visualized on a long wave 360 nm UV transilluminator and photographs taken using a 
Polaroid MP4 camera and Polaroid 637 film.
2.4.6 Extraction of DNA from agarose gels
DNA was recovered from agarose gels using the QLAquick Gel Extraction kit (Qiagen, UK), 
in accordance with the manufacturer’s instructions.
2.4.7 Ligation of plasmid DNA
Ligation of vector and foreign DNA was carried out as described by Sambrook et al., 1989. 
Reactions were set up by mixing 50 ng of vector DNA with an equimolar amount of insert 
DNA. The following equation was used to determine the required amount of insert DNA: 
ng of vector x kb size of insert
X insert: vector molar ration = ng of insert
kb size of vector
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The ligation reaction mixture was made up to a final volume of 10 pi by the addition of 1 pi 
DNA ligase buffer (10*), 1 pi of 1 U/pl T4 DNA ligase (Helena BioSciences) and Milli-Q 
water. The reaction was incubated at 16°C for 1 to 16 hours. Usually, 1 to 2 pi of each 
ligation reaction used to transform E. coli cells.
The pGMT-T Vector System (Promega) was used since it is a convenient system for cloning 
PCR products. This plasmid is provided in a linearized form with a single thymidine overhang 
at both its 3’-ends. The presence of these overhangs greatly improves the efficiency of 
ligation of PCR products, which possess complementary 3’-adenine overhangs. Ligation 
reactions were carried out as instructed by the manufacturer.
2.4.8 Preparation of competent E. coli JM109 cells
A single fresh colony of E. coli JM109 was inoculated into 5 ml LB broth and incubated 
overnight at 37°C with aeration (200rpm). This primary culture was diluted 1:100 and grown 
until the OD470 reached 0.48. The suspension was chilled on ice for 5 minutes, and then 
centrifuged at 4,000* g  for 5 minutes at 4°C. The supernatant was discarded and the cells 
were resuspended in 2/5th volume of transforming buffer I (30 mM KC1, 100 mM RbCl, 10 
mM CaCE, 50 Mm MnCL2 , 15% v/v glycerol, pH 5.8) and chilled on ice for 5 minutes. The 
cells were centrifuged at 4,000* g for 5 minutes at 4°C and supernatants discarded. The cells 
were then resuspended in l/25th volume of transforming buffer II (10 mM MOPS, 75 mM 
CaC12, 10 mM RbCl, 15% v/v glycerol, pH 6.5) and left on ice for 15 minutes. Finally, the 
cell suspension was divided into 2 0 0  pi aliquots and snap frozen on dry ice/ethanol and stored 
at -70°C until required.
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2.4.9 Transform ation of competent E. coli JM109 by heat shock
Competent cells were thawed at room temperature and then chilled on ice for 10 minutes. The 
DNA was added and the suspension was mixed gently and left on ice for 30-45 minutes. Heat 
shock was carried out at 42°C for 2 minutes and then immediately cells were cooled on ice for 
2 minutes. Four volumes of LB broth were added and the suspension was incubated at 37°C 
for 1 hour. The cells were pelleted and suspended in 100 pi LB broth. All of the mixture was 
plated out onto LB agar plates containing appropriate antibiotic.
2.4.10 Blue/white selection
For growing and screening of transformed bacteria containing the correct insert, selective 
plates were spread with 4 pi of 0.2 mM isopropyl-P-D-thiolgalactoside (IPTG) and 40 pi of 
X-Gal (5-bromo-4-chloro-3-indoyl 0-D galactopyranoside) (20 mg/ml in 
dimethylformamide). The plates were dried at 37°C for 4 hours. Bacterial colonies containing 
the recombinant plasmid appeared white, whilst those having the intact lacZ gene appeared 
blue.
2.4.11 Preparation of plasmid DNA
Small-scale plasmid extraction was performed using the Wizard Plus SV Mini Prep kit 
(Promega, Madison, WI), in accordance with the manufacturer’s instructions.
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2.4.12 Purification of DNA by ethanol precipitation
Ethanol precipitation was used to clean up and/or concentrate DNA. For the DNA sample 0.5 
volumes of ammonium acetate (7.5 M) and 2.5 volumes of 95% ethanol were added to 1 
volume of sample. The resulting mixture was centrifuged at 14,000x g  for 15 minutes, after 
which the supernatant was discarded. The pellet was then rinsed in 250 pi of 70% ethanol and 
centrifuged at 14,000* g for 5 minutes. Finally, the ethanol was removed, the pellet air-dried 
and the DNA suspended in 10-25 pi of TE (Tris/EDTA) buffer pH 8.0 or water.
2.4.13 Restriction plasmid DNA
DNA restrictions were carried out using enzymes purchased from Fermantas. A 20 pi or 50 pi 
reaction containing the DNA, the enzyme (5-20 U/pg plasmid DNA) and an appropriate 
buffer, were incubated at 37°C for 1 to 4 hours. The reaction was terminated by addition of
12.5 mM EDTA (pH 8.0) or by heating the solution to 65°C for 20 minutes. Digests were 
analyzed by agarose electrophoresis.
2.4.14 Sequencing DNA constructs and computer assisted sequence analysis
DNA Sequencing was carried out at the automated DNA sequencing facility in the 
Department of Biology and Biochemistry at the University of Bath. Sequence analysis was 
performed using the Wisconsin Genetics Computer Group (GCG) software package on the 
University of Bath GNOME Unix server. The BLAST search facilities of the National Library
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of Medicine, Washington, DC (NCBI) (http://www.ncbi.nlm.nih.gov), were used to search 
for homologues.
2.5 Methods of statistics
Statistical analysis was used in two contexts in this work. Firstly, data for nitrite production 
by A549 cells were assessed by 2-way analysis of variance, followed by Dunnett’s test 
(multiple comparisons to control group) or Tukey’s test (comparison at all means) as 
appropriate. P  value of less than 0.05 was considered significant. Secondly, for bacterial 
killing experiments significant differences between killing activities in different isolates was 
assessed by paired or unpaired t-tests on logio transformed data. Again, p  value of less than 
0.05 was considered significant.
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3. Modulation of inducible nitric oxide synthase 
expression
3.1 Background
The inflamed pulmonary epithelium is an important source of inducible nitric oxide 
synthase in the lung, which will lead to a tonic expression of NO detected in exhaled 
air. This suggests that iNOS activity has regulatory roles in pulmonary epithelial cells, 
which can range from bactericidal activity to the regulation of gene expression. This 
emphasizes the significance of the detailed understanding of intracellular events 
regulating the expression of iNOS in human respiratory epithelial cells as a prerequisite 
to understanding the role(s) of iNOS in lung biology and disease. The vulnerability of 
CF patients to chronic pulmonary bacterial infections has been attributed, in part, to 
alterations in NO production. Various reports have demonstrated that the iNOS isoform 
is constitutively expressed in tracheal and nasal epithelial cells in normal human (Guo et 
al., 1995). However, Kelley and Drumm, (1998) clearly showed, through immuno- 
staining, that iNOS is absent in the epithelium of CF airway. Their findings offered a 
possible explanation for the lack of exhaled NO in CF expired air. Conversely, other 
investigations did not agree on an explanation for the lack of exhaled NO from CF 
patients (Robbins et al., 2000; Jones et al., 1998), and attributed this to other 
phenomena not associated with dysregulation of iNOS. Some studies did not find a 
decrease in NO from orally exhaled air in CF patients. However, exhaled NO gas may 
not be a good marker for iNOS activity in the CF airway (Linnane et al., 1998), and 
there was clearly a lack of increased NO levels that would be expected in an
MODULATION OF iNOS EXPRESSION 62
CHAPTER 3
inflammatory disease (Grasemann et al., 1997; Kelley and Drumm, 1998). In vitro 
studies using human colon epithelial cells revealed that IL-13 downregulates iNOS 
expression via upregulation of phosphatidylinositol 3-kinase (Wright et al., 1997).
3.2 Results
3.2.1 Cytokine-induced iNOS activity
Using A549 cells as model of human pulmonary epithelial cells, initial investigations 
sought to confirm the mechanisms involved in nitric oxide production and regulation by 
T cell-derived cytokines.
The approach undertaken to investigate the regulation of iNOS in human pulmonary 
epithelium was to investigate firstly that A549 cells produce elevated levels of NO in 
response to treatment with pro-inflammatory cytokines and secondly, mechanisms 
modulating iNOS activity.
Growth arrested monolayers of unstimulated A549 produced a small constitutive 
amount of nitrite, the stable breakdown product of NO (Fig 3.1). To determine whether 
the individual stimuli would induce iNOS, the pro-inflammatory cytokines IL-lp (0.3 
ng/ml), TNF-a (30 ng/ml) and IFN-y (50 ng/ml) added individually did not induce 
significant increases in nitrite generation after 24 hours compared with the constitutive 
nitrite basal level in untreated A549. The combination of IFN-y/IL-lp was the minimal 
requirement to induce nitrite production, whilst other pairs of cytokines caused a slight 
increase in nitrite levels. Stimulation by IFN-y/ IL-lp produced a moderate increase in 
nitrite production of 1.75 ± 0.2 pM (n=3). The addition of IFN-y to the combination of







Fig. 3.1. Nitrite production by A549 cells stimulated with 
cytokines, as indicated for 24 hours. Each point represents 
the mean ± SEM of at least three experiments.
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IL-ip/TNF-a resulted in a significant increase in nitrite. The combination of three 
cytokines resulted in an approximates of 3-fold enhancement in nitrite levels, i.e. 3.5 ± 
0.1 pM (n=3) (Fig.3.1).
Based on dose response studies, there was a concentration dependent increase in nitrite 
production at different levels by the pair-wise combination of TNF-a/IFN-y, IL-ip/IFN- 
y, after 24 hours of induction (Fig 3.2A and B, respectively). Each of IL-1 P (0.1 - 10 
ng/ml) or TNF-a (1 - 100 ng/ml) was used simultaneously with IFN-y (50 U/ml) and 
nitrite levels were enhanced as doses of each of IL-lp or TNF-a increased. However, 
the synergy of the IL-ip /IFN-y or TNF-a /IFN-y was mild and nitrite levels at maximal 
concentrations of IL-1 p (10 ng/ml) or TNF-a (100 ng/ml) were 1.75 ± 0.25 and 1.42 ± 
0.11 pM, respectively (Fig. 3.2A and B). Accordingly, the sub-maximal concentrations 
of IL-lp (3 ng/ml) and TNF-a (30 ng/ml) were selected to test for the synergy of IL-lp 
and TNF-a with IFN-y (0.5 - 100 U/ml). Interestingly, different concentrations of IFN-y 
(0 - 100 U/ml) in the presence of the combination of IL-1 p (3 ng/ml) and TNF-a (30 
ng/ml) induced a concentration-dependent enhancement of nitrite production (Fig. 
3.2C). The sub-maximal concentration of IFN-y (50 U/ml) was selected and used in 
subsequent experiments.
Stimulation of A549 cells with IL-ip (3 ng/ml), TNF-a (30 ng/ml) and IFN-y (50 U/ml) 
induced a time-dependent generation of nitrite at 4 (0.994 ± 0.025), 8 (1.55 ± 0.24), 12 
(1.86 ± 0.29), 24 (2.4 ± 0.44) and 48 (3.14 ± 0.48) hours compared with basal values of 
0.74 ± 0.5 pM (Fig. 3.3).
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Fig 3.2. Nitrite production by A549 cells after 24 hours treatment 
with different concentrations of (A) TNF-a (0-100 ng/ml) in the 
presence of IFN-y (50 U/ml), (B) IL-lp(0-10 ng/ml) in the presence of 
IFN-y (50 U/ml) and (C) IFN-Y (0-100 U/ml) in the presence TNF-a 
(30 ng/ml) and IL-lp (3.0 ng/ml). Each point is the mean ± SEM of 
three experiments. Significant nitrite increase compared with 0 value 
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Fig. 3.3. Time course of nitrite production by A549 cells following 
stimulation with cytokine mixture of TNF-a (30 ng/ml), IL-lp (3.0 
ng/ml), and IFN-y ( 50 U/ml). Each point represents mean ± SEM of 
at least three experiments. Significant increase in nitrite production 
by time incubation compared with 0 hour incubation are indicated by 
NS (p>0.05), * (p<0.05) and **(p<0.01).
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3.2.2 Regulation of iNOS activity by NOS substrate inhibitors
Much effort have been given to the design of selective inhibitors of NOS isozymes to be 
used as biological tools and more importantly as possible pharmacological tools to 
modulate NO levels. The expression ‘selective inhibitor’ can be used if the inhibitory 
effect is against a particular NOS isoform, and inhibition was shown at the isolated 
enzyme level ideally in vivo (Alderton et al., 2001). Thus, 1400W developed by Garvey 
et al. (1997) as a highly selective inhibitor for iNOS, was used to verify that the nitrite 
measured was the result of NO generated by iNOS activity. Another well-characterised 
NOS inhibitor used in this study was aminoguanidine. Aminoguanidine has partial 
selectivity for iNOS versus eNOS, however, its selectivity over nNOS is minimal 
(Alderton et al., 2001).
Thus, the effects of 1400W and aminoguanidine were measured on cells treated with the 
cytomix, the combination of cytokines IFN-y/TNF-a/IL-lp.
Co-stimulation of A549 cells with pro-inflammatory cytokines and iNOS inhibitors 
resulted in 96 ± 4% (n=3) inhibition of nitrite accumulation by 1400W (10 pM) and by 
96 ± 0.7% (n=3) inhibition by aminoguanidine (0.5 mM). However, the inhibitory effect 
of both 1400W and aminoguanidine (0.5 mM) did not affect the minimal level of nitrite 
when treated with unstimulated A549. This was indicated with no change to the basal 
levels of nitrite after 1400W (10 jliM ) or aminoguanide (0.5 mM) stimulation (Fig. 3.4).









Fig. 3.4. Effect of iNOS inhibitors aminoguanidine (0.5 mM) and 
1400W (10 jiM) on stimulated A549 with cytokine mixture of 
TNF-a (30 ng/ml), IL-1 (3 (3.0 ng/ml), and IFN- y(50 U/ml) for 24 
hours. Each point represents mean ± SEM of at least three 
experiments. Significant inhibition of nitrite by addition of iNOS 




3.2.3 Effect of IL-13 on cytokine-stimulated nitrite production
Data indicated that IL-13 could be a potent modulator of immune responses in different 
types of cells, including suppression of NO synthesis. In vitro, IL-13 inhibited iNOS 
induction in human colon epithelial cells HT-29 (Wright et al., 1997) and in A549 cells 
(Berkman et al., 1996). Downregulation of pro-inflammatory cytokine induced iNOS in 
HT-29 cells was via activation of PI 3-kinase by IL-13. Such a scenario of cell 
signaling, might explain the dysregulation of iNOS in the CF lung. The A549 cell line 
in this work was used as a model to explore the regulation by IL-13 of pulmonary 
epithelial iNOS activity. IL-13 had an inhibitory effect on IFN-y/TNF-a/IL-lp induced 
nitrite generation. Confluent monolayers of A549 were pretreated for 1 hour with 
increasing concentrations of IL-13 (0.3 - 30 ng/ml), followed by the combination of 
cytokines IFN-y/TNF-a/IL-l(3 for 24 hours. IL-13 produced a partial but a significant 
suppression of nitrite levels (Fig. 3.5). In order to test whether IL-13 can inhibit iNOS 
from stimulated A549 cells via PI 3-kinase signaling, inhibitors were used. The addition 
of the PI 3-kinase inhibitor wortmannin (10 - 300 nM) to A549 cells 10 minutes before 
IL-13 treatment partially prevented the inhibitory effect of IL-13 on cytokine-induced 
nitrite production from iNOS (Fig. 3.6). Similarly, addition of the structurally unrelated 
PI 3-kinase inhibitor LY294002 (1 -  30 (iM) for 15 minutes before IL-13, resulted in 
partial restoration o f nitrite levels from cytokine stimulated A549 cells (Fig. 3.6). Taken 
together, these data suggest a role for PI 3-kinase in transduction of the IL-13-induced 
signal, which down-regulates iNOS activity.
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Fig. 3.5. Effect of IL-13 on cytokine stimulated nitrite production 
in A549 cells. A549 cells were treated with increasing concentra­
tions of IL-13 (0.3-30 ng/ml)for 1 hour prior to the addition of 
cytokines, as indicated. Each point represents the m eant SEM of 
three separate experiments. Significant reduction in nitrite levels 
by different concentrations of IL-13 compared with cytokine stimulated 
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Fig 3.6. Nitrite production by A549 cells after treated with wortmannin 
for 10 minutes or LY294002 for 15 minutes prior to the addition of IL- 
13 for 1 hour, followed by cytokines, as indicated, after 24 hours, 
nitrite in the supernatant was measured using the fluorometric nitrite 
assay. Data are the mean ± SEM of three experiments. Significant 
nitrite restored levels after PI 3-kinase inhibiters compared with 
cytokine stimulated A549 pretreated with IL-13 indicated by NS 
(p>0.05), * (p<0.05) and **(/?<0.01).
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3.2.4 Regulation of iNOS by substrate limitation
According to Murphy and Newsholme (1998); Chang et al. (2000), the lack of NO 
release by human mononuclear phagocytes and murine macrophages, respectively, is 
due to an increased breakdown of the NOS substrate L-arginine, by another enzyme, L- 
arginase. More interestingly, in the recent study by Chang et al. (2000) it was 
demonstrated that activity of IL-13 mediated inhibition of iNOS was via its ability to 
induce L-arginase. The question then was raised as to whether arginase plays a 
regulatory role in NO production in A549 cells. Three lines of investigations were 
taken, firstly a study of the effect of the extracellular L-arginine supply on NO 
production, secondly assay for arginase activity in A549 and thirdly investigate if IL-13 
modulates iNOS expression through arginase induction.
Upon addition of an excess amount of the substrate, L-arginine (2 mM) to the DMEM 
medium the standard curve for the flourimetric nitrite assay was not altered (Fig. 3.7). 
However, NO levels increased 39 ± 10% from unstimulated A549, 22 ± 9% from 
cytokine-stimulated A549 and 32 ± 6% after IL-13 treated cytokine stimulated A549 
when grown in DMEM containing an excess of L-arginine (2 mM) for 24 hours. The 
presence of excess substrate L-arginine, had no significant effect (p = 0.6) on the 
change of nitrite from cytomix -induced A549 treated with or without IL-13 (Fig. 3.8).
Lysates of unstimulated as well as cytokine-stimulated A549 failed to convert L- 
arginine to urea after being activated at 55-60°C for 10 min. In parallel there were no 
detected increases in NO accumulated from cytokine-stimulated and unstimulated 
A549, after the addition of L-norvaline, which is an arginase inhibitor. To observe dose
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dependence of L-norvaline on nitrite accumulation from cytokine-stimulated A549, 
increased concentrations of L-norvaline (5-20 mM) added resulted in no increase in 
nitrite accumulation from cytokine stimulated A549 (Fig. 3.9). The addition of L- 
norvaline (20 mM) did not reverse IL-13 inhibition of nitrite production (Fig. 3.10).
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Fig. 3.7. Effect of addition of excess amounts of L-arginine 
on nitrite standard curve. The continuous line represents fluorescence 
of sodium nitrite in DMEM without L-arginine supplement and 
dashed line is sodium nitrite fluorescence in DMEM with 
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Fig. 3.8. Effect of excess extracellular L-arginine (2 mM) in 
DMEM medium, on nitrite production by A549 cells after 
treatment with cytokine mixture for 24 hours in the presence or 
absence of IL-13 (30 ng/ml) added 1 hour prior to cytokine 
stimulation. Each point is the mean ± SEM of three experiments. 
Significant changes in nitrite levels of cytokine stimulated A549 
after IL-13 treatment with and without additional L-arginine are 
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Fig. 3.9. Effect of L-norvaline (0-50 mM) on nitrite production 
by A549 cells after stimulation with cytokine mixture as 
indicated. Each point is the mean ± SEM of three experiments. 
NS and ** represent significant (p>0.05 and /?<0.01 
respectively) of L-norvaline addition compared with 0 addition 
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Fig. 3.10. Effect of L-norvaline (20 mM) on nitrite production by A549 
cells treated with cytokines as indicated for 24 hours. Each point 
is the mean ± SEM of three experiments. Significance of changes in nitrite 
production after the addition of L-norvaline compared with basal nitrite 
levels represented by NS ( p>0.05), while significant change in nitrite levels 
to cytokine-stimulated A549 after the IL-13 with and without the addition 





The pulmonary epithelium, an integral component of the alveolar-capillary wall, serves 
multiple functions in the lung since it acts as a physical barrier between the external and 
internal environments. Because of the proximity of alveolar macrophages it has always 
been considered as a target of inflammatory cells rather than as an active participant in 
generation of an inflammatory response (Simon et al., 1986). Recently, it has been 
shown that the pulmonary epithelium plays a significant role not only in the production 
of inflammatory cell chemoattractants (Standiford et al., 1990; Palffeyman et al., 1997), 
but also as a major and continuous cellular source of iNOS in the lung (Kobzik et al., 
1993; Guo et a l, 1995). However iNOS expression by pulmonary epithelial cell lines is 
present only when cell lines in vitro are challenged with inflammatory components 
(pro-inflammatory cytokines).
A frequently posed question is: what is the most suitable cell culture model to study NO 
derived from pulmonary epithelium? The human pulmonary epithelial cell line A549 is 
an alveolar type II epithelium derived from a lung adenocarcinoma derived from a 58 
year old Caucasian male (Koichiro et al., 1994). A549 cells are a well-established 
alveolar epithelial cell line and used in various investigations as a model for in vitro 
characterization of human alveolar epithelial cell functions. Robbins et al. (1994), 
Asano et al. (1994), Berkman et al. (1996), Chu et al. (1998) and Kwon et al. (2001) 
have demonstrated that A549 expresses iNOS and produces NO in response to pro- 
inflammatory cytokines. In contrast to these studies, Pechovsky et al. (2001) and 
Donnelly and Barnes (2002) showed that A549 has a different pattern of NOS isoform
MODULATION OF iNOS EXPRESSION 79
CHAPTER 3
expression and neither iNOS mRNA nor protein could be detected from cytokine- 
stimulated or non-stimulated A549.
In this study, unstimulated A549 produced a small amount of nitrite, which may be due 
to constitutive NOS activity, eNOS or nNOS. None of the pro-inflammatory cytokines 
added alone increased nitrite generation. The combination of IL-lp and IFN-y caused an 
increase in nitrite generation in A549, whilst the TNF-a and IFN-y combination was not 
as effective. The combination of IL-lp/TNF-a/ IFN-y was the most effective to increase 
nitrite generation. It is most likely that the increased nitrite levels is due to iNOS 
enzyme activity because this activity was first, induced via a combination of pro- 
inflammatory cytokines and second, was inhibited by the iNOS by 1400W and also by 
aminoguanidine. These data suggest that A549 cells can be used to study nitric oxide 
production and regulation.
The low levels of nitrite produced in unstimulated A549 may be contributed to one or 
two types constitutive isoforms of NOS. Asano and associates (1994) have studied 
eNOS, nNOS and iNOS expression by RT-PCR in A549 cells. No evidence of eNOS 
(NOS3) expression was found, however, large amounts of iNOS mRNA were detected 
in cytokine-stimulated cells.
In a recent study to understand the transcriptional regulation of the human iNOS gene, 
the promoter of iNOS in A549 has been cloned, sequenced and characterized (Chu et 
al., 1998). Consistent with the above results, their data demonstrated that iNOS mRNA 
was elevated in A549 cells maximally, when incubated with the cytokine combination 
mixture IL-ip/TNFa/IFN-y and intermediately, when stimulated with pairwise 
combinations of cytokines. Single cytokines produced little effect. The synergistic
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mechanism of cytokine-induced iNOS in A549 has been studied by Kwon et al., (2001). 
They demonstrated that single cytokine stimulation led to iNOS monomer production, 
but only IL-113 and INF-y exposure resulted in formation of the cofactors necessary to 
form the functional iNOS. The combination of cytokines activated the transcriptional 
factor NF-kB that augments iNOS mRNA transcription for subsequent translation.
The maximal induction of iNOS was observed only after addition of IFN-y, indicating 
that IFN-y is likely the most important component. Results from various investigations 
showed that IFN-y acting in concert with pro-inflammatory cytokines potentiated that 
transcription of iNOS from various cell types (MacMicking et al., 1997; Martin et al., 
1994).
The results in this work are similar to those found in cultured cells of human heptocytes 
(Nussler et al., 1992), colon epithelial cells (Kolios et al., 1995), mesangial cells 
(Nicolson et al., 1993) and most importantly lung epithelial cells (Asano et al., 1994; 
Robbins et al., 1994; Chu et al., 1998; Kwon et al., 2001).
Time course studies with the combination of three cytokines demonstrated that the 
nitrite generation peak occurred between 24 and 48 hours after cytokine mixture 
stimulation. This time may be needed for protein translation or co-factor generation. In 
HT-29 colon epithelial cells, iNOS mRNA peaked at 24 hours and was undetectable at 
72 hours (Kolios et al., 1995). Nussler et al. (1992) and Geller et al. (1993) 
demonstrated that iNOS mRNA from human hepatocytes peaked after 8 hours after 
stimulation, and nitrite generation peaked at 48 hours. This gap between maximum 
enzyme message expression and maximum nitrite generation is required for de novo
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synthesis o f co-factors such as tetrahydrobiopterin (Stuehr and Giffith, 1992; Nussler et 
a l , 1992).
Following the discovery that L-arginine is the substrate for NO biosynthesis in most cell 
types, Hibbs in 1987 identified N®-substituted L-arginine analogues that suppressed 
NO-mediated cytotoxicity (reviewed by Whittle, 1995). Comparison studies 
demonstrated that A^-amino-L-arginine, followed by A^-monomethyl-L-arginine (L- 
NMMA) are effective inhibitors of iNOS activity in cytokine-stimulated macrophages 
and endothelial cells. From then, a variety of -substituted-L-arginine derivatives have 
been investigated, which basically compete with L-arginine for binding sites in the NO 
synthase enzymes and so inhibit their activity (Green and Nacy, 1993).
Because of the very high structural homology between iNOS and eNOS, identification 
of selective inhibitors has been difficult. The acetamide-containing analogues of 
arginine, such as aminoguanidine, which is a nucleophilic hydrazine compound, have 
been proposed to be highly selective for iNOS without affecting eNOS. It was found 
that aminoguanidine is at best only 30-fold more potent against iNOS than eNOS. 
Garvey et a l (1997), showed that N-(3-(aminomethyl)benzyl)acetamine (1400W) to be 
a slow, irreversible inhibitor of human iNOS. 1400W was more than 5000 and 250-fold 
more selective for iNOS versus both nNOS and eNOS, respectively. Its blocking 
reaction is an irreversible competitive inhibition with L-arginine, is NADPH-dependent 
and develops fairly slowly, and no significant reversal of this inhibition was observed 
after 2 hours. This compound shows potential as a new therapeutic agent (Alderton et 
a l , 2001; Koarai, 2000). In this study, pretreatment with 1400W and the less selective
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inhibitor aminoguanidine, almost completely abolished the cytokine-induced nitrite 
induction from A549 cells. Thus, it is most likely that the increased nitrite levels are due 
to upregulation of iNOS enzyme activity
Interleukin-13 is the most recently identified cytokine to join the T helper 2 (Th2) 
cytokine family. It is distantly related to IL-4. It has been demonstrated to induce a 
variety of immunomodulatory functions on a wide range of cell types restricted to 
activated T lymphocytes, especially Th2 cells, mast cells, basophils, dentritic cells and 
natural killer (NK) cells highlighting its pleiotropic activities (Brombacher, 2000). The 
induction o f iNOS in pro-inflammatory cytokine stimulated A549 was partly suppressed 
by IL-13. IL-13 produced a concentration related inhibition of nitrite accumulation 
induced by the optimal cytokine combination IFN-y/TNF-a/IL-ip for 24 hours. 
Inhibition was maximal at the high concentration of IL-13 (30 ng/ml) added one hour 
prior to cytokine stimulation IFN-y/TNF-a/IL-ip. This important inhibitory effect of IL- 
13 on cytokine-stimulated iNOS, was previously shown in macrophages (Liew et al., 
1991; Doherty et al., 1993) and human pulmonary epithelium A549 cell line (Berkman 
et al., 1996). These observations implied that the inhibitory effect of IL-13 was at the 
transcriptional level and suggested to be through other transcriptional factor(s), since 
IL-13 inhibition was reversed after addition of cycloheximide, which is a protein 
synthesis inhibitor. However, it was demonstrated using the human colonic epithelial 
cell line HT-29, that IL-13 could downregulate iNOS through the activation of 
phosphatidylinositol 3-kinases (PI 3-kinase) (Wright et al., 1997).
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Phosphatidylinositol 3-kinases are a growing subfamily of lipid kinases that catalyze the 
addition of a phosphate molecule to the hydroxyl group at the D3- position on the 
inositol ring of phosphoinositide lipids (Wymann and Pirola, 1998; Fruman and 
Cantley, 2002). Phosphatidylinositol (PI), the precursor of all phosphoinositides, 
constitutes less than 10% of all total lipids in eukaryotic cell membranes. However, less 
than 0.23% of the total inositol-containing lipids are phosphorylated at the 3-position, 
consistent with the idea that these lipids exert specific regulatory functions inside the 
cell, as opposed to a structural function (Rameh and Cantley, 1999).
The concept that increased PI 3-kinase activity negatively regulates iNOS has been 
adopted and studied by other investigators at the molecular level. For example, 
expression of a constitutively active class 1a p i 10 subunit of PI 3-kinase attenuated 
iNOS promoter activity in LPS activated macrophages (Diaz-Guerra et al., 1999) as 
well as inhibited cytokine-induced iNOS in astrocytes (Pahan et al., 1999). Together, 
these data suggest that inhibition of PI 3-kinase activity may be significant for iNOS 
stimulation.
The exact mechanism underlying the regulation of iNOS expression via PI 3-kinase is 
not clear yet. One candidate mechanism involves the transcription factor N F -kB , which 
regulates the transcription of human iNOS (Guo et al., 1997). IL-13 has been shown to 
inhibit NF- kB  activation in a number of cell models including alveolar macrophages 
(Lentsch et al., 1997; Manna and Aggarwal, 1998).
The exact signaling cascade that modulates the activity of iNOS via IL-13 is not well 
characterized. To investigate the relevance of PI 3-kinase to the activity of IL-13, PI 3- 
kinase inhibitors have been used. Nitrite levels have been partially restored when
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wortmannin and LY294002 have been added prior to IL-13 and cytokine stimulation of 
A549.
The use of chemical inhibitors of PI 3kinase provides a fast and easy way to explore the 
importance of this enzyme in any cell surface receptor-mediated signaling pathway. 
Wortmannin (Wymann et al., 1996) and LY294002 (Vlahos et al., 1994) are effective 
selective inhibitors of PI 3-kinase that have helped to define the PI 3-kinase signaling 
pathways. Wortmannin is classified as a non-competitive inhibitor at nanomolar 
concentrations, while LY294002 competitively inhibits PI 3-kinase at micromolar 
concentrations (Wymann et al., 1996). It was demonstrated that wortmannin and 
LY294002 restored partially the expression of iNOS in HT-29. Recently, wortmannin 
has been involved in the inhibition of PI 3-kinase in colonic epithelial cells and the 
induction of N F -kB  independently of any effect on I kB  (Wang et al., 2000).
It was already established that induction of iNOS to produce high levels of NO is 
dependent on an adequate L-arginine supply (Moncada and Higgs, 1993; Nathan and 
Xie, 1994). Besides iNOS, there is another major L-arginine-consuming enzyme, 
arginase (Fig. 3.11), which was found to be highly active in activated murine 
macrophages (Granger et al., 1990; Schneider and Dy, 1985). In addition, it was 
demonstrated that IL-13 down-regulates NO by substrate depletion through Stat-6 
production of arginase in activated murine macrophages (Rutschman et al., 2001). We 
postulated that competition between arginase and NOS, and cytokine-stimulated iNOS 
in particular, for their common substrate L-arginine could be a limiting factor for NO 
production. We predicted that if  IL-13 modulates iNOS via stimulating arginase, L- 
arginine will be depleted and nitrite levels from cytokine-stimulated iNOS will be
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Fig. 3.11. Regulation of nitric oxide production by arginine metabolic enzymes. 
NOS; nitric oxide synthase, NO, nitric oxide .
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reduced. Consequently, supplying excess extracellular L-arginine would restore nitrite 
levels, but this did not happen. IL-13 pretreatment inhibited nitrite accumulation from 
cytokine stimulated A549 and addition of extracellular L-arginine did not restore nitrite 
levels. The slight elevation of nitrite from unstimulated as well as cytokine-stimulated 
A549, however, may be due to cNOS or iNOS activity as abundant supply of the 
extracellular substrate is available for utilization.
No arginase activity could be detected in A549 cells. An arginase inhibitor, L-norvaline, 
was used to detect any change in cytokine-induced iNOS activity. L-norvaline is a 
nonmetabolizable analogue of L-valine, which has structural similarity to ornithine. 
Ornithine is an end product of arginase pathway and it was shown to inhibit arginase 
indirectly (Wu et al., 1998). However the inhibitory effect of L-norvaline was 
demonstrated at the enzyme kinetic level, without affecting iNOS activity (Chang et al., 
1998). The inhibition of arginase by L-norvaline would increase substrate availability 
for cytokine-stimulated iNOS and more nitrite accumulation would be expected. 
However, L-norvaline did not cause an increase in nitrite levels from cytokine- 
stimulated as well as unstimulated A549. More importantly, if IL-13 modulated iNOS 
activity through arginase, L-norvaline and IL-13 pretreatment to stimulated A549 would 
restore nitrite level but again this did not occur. Accordingly, L-arginine is not a 
limiting factor in the stimulated iNOS and IL-13 does not modulate iNOS activity 
through arginase activity in the pulmonary epithelial cell line A549.
Following initial reports that NO synthesis and arginase were co-induced in 
macrophages, several laboratories established that iNOS might be regulated through 
arginase activity. Most of these studies hypothesized that substrate competition is the
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key. In reality, the basis for interplay between arginase and NOS is more complex than 
the fact that they use a common substrate. For example, iNOS-expressing macrophages 
and endothelial cells can produce sufficient vV03-hydroxyarginine, an intermediate in the 
NOS catalyzed conversion of L-arginine, to inhibit arginase activity (Fig. 3.11). Since 
endothelial cells in intact animals are perfused, whereas cultured cells are not, it is not 
clear that the former would be exposed to sufficient TV03-hydroxyarginine to inhibit 
cellular arginase activity. In addition it must be taken into consideration that the 
arginine concentrations in culture media are up to ten times higher than plasma arginine 
concentrations, so that rates of TV03-hydroxyarginine production in culture media are 
probably greater than in vivo (Muijsers et al., 2001). There are two isoforms of arginase 
in vertebrates, both of which catalyse the conversion of arginine to ornithine and urea. 
They differ with regard to subcellular localization, tissue distribution, and certain 
enzymatic properties, reflecting the fact that they are encoded by different genes 
(Jenkinson et al., 1996). Type I Arginase (Al), a cytosolic enzyme, is highly expressed 
in human liver and to a limited extent in a few other cells, like neutrophils and rat 
endothelial cells. In contrast, type II arginase (All), a mitochondrial enzyme, is 
expressed in lower levels in kidney, brain, small intestine, mammary gland and 
macrophages, with little or no expression in liver. In an in vivo study, Al, and not All 
was demonstrated to be induced by LPS in the lung and down-regulated NO from LPS 
stimulated iNOS (Sonoki et al., 1997). As stated earlier, several studies demonstrated 
the co-induction of arginase and iNOS in macrophages, however, none of these studies 
compared the relative potency of Al and All in regulation of NO production. It seems
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that if NO levels are high both arginase isoforms are equally effective in inhibiting NO 
production by limiting L-arginine availability to iNOS (Que et al., 2002).
In summary, A549 cells can be induced by a combination of pro-inflammatory 
cytokines to express iNOS. The iNOS substrate inhibitors and the anti-inflammatory 
cytokine IL-13 can modulate the activity of iNOS, whereas arginase has no role in 
iNOS regulation in A549. In conclusion, these data are consistent with the hypothesis 
that aberrant regulation of NO activity in CF could be due to perturbed PI 3-kinase 
signaling.
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4. Antioxidant enzymes of B. cepacia strains
4.1. Catalase activity of Burkholderia cepacia strains
In aerobic organisms the metabolism of oxygen can result in the production of large 
quantities of toxic reactive intermediates such as superoxide (O2 ), hydrogen peroxide 
(H2O2) and hydroxyl radicals (OH-) that readily react with various cellular components 
causing lethal damage. Thus oxidative stress is an inevitable consequence of aerobic 
life. As well, pathogens face the additional challenge of oxidative intermediates 
produced by neutrophils and macrophages. Upon infection, these phagocytes suddenly 
increase oxygen consumption and produce reactive oxygen intermediates in a process 
termed the respiratory stress (Brown et al., 1995; Halliwell and Gutteridge, 1999). 
Superoxide dismutase (SOD) and catalase are well-known examples of antioxidant 
enzymes utilized by prokaryotes. SOD detoxifies O2- anions by a dismutation reaction 
that generates H2O2 and O2 , while catalase converts toxic H2O2 to O2 and H2O 
(Fridovich, 1978). The monofunctional catalase (HPII) is expressed in most aerobic 
bacteria from the KatE gene. Multiple catalase KatE isozymes have been observed in 
response to oxidative stress and growth conditions (Christman et al., 1985; Loewen et 
al., 1985a; Katsuwon and Anderson 1992; Loewen, 1996; Vattanaviboon and 
Mongkolsuk, 2000).
Previous work indicated that B. cepacia complex isolates, survive intracellularly within 
murine macrophages (Saini et al., 1999) and human macrophages (Martin and Mohr, 
2000), respiratory epithelial cell lines (Bums et al., 1996) and free-living amoebae 
(Marolda et al., 1999). The ability of B. cepacia strains to survive intracellularly is
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mainly attributed to their ability to resist and inhibit the toxic effects of reactive oxygen 
species. Since B. cepacia isolates are known to produce catalase and SOD (Lefebre and 
Valvano, 2001) both enzymes are thought to protect B. cepacia from oxidative damage 
and may contribute to intracellular survival. However, intracellular survival does not 
appear to be a function common to all strains of B. cepacia complex (Martin and Mohr, 
2000). In addition, Smith et al. (1999) observed variations in the lethal response by NO 
and H2O2 among strains of B. cepacia. Our hypothesis is that there may be variations in 
catalase (KatE) activity between strains of B. cepacia that may contribute to variations 
in susceptibility to oxidative killing. Thus, the targets were to investigate catalase 
(KatE) activity of four selected strains of B. cepacia, and to isolate and sequence the 
katE gene from JL2315 which was not killed by H2O2 in Smith and coworkers’ study 
(Smith et al., 1999).
The biofilm mode of bacterial growth is the preferred form of bacterial existence in 
nature and it has been observed that the production of catalase and SOD vary in P. 
aeruginosa when grown as biofilm when compared with planktonic culture (Hassett et 
al., 1999a and 1999b; Bollinger et al., 2001). Since B. cepacia cells may also grow as a 
biofilm in the CF lung, catalase activity was investigated from the four strains of B. 
cepacia grown as biofilm in parallel with planktonic cultures.
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4.2 Results
4.2.1 Planktonic and biofilm growth phase variations of B. cepacia strains
The strains J2315, J2552, JL27 and JL32 were selected for this study. The strains J2315 
and JL27 produced similar macroscopic cultural characteristics when grown on LB 
agar. Colonies of both strains were pin-point, dry, opaque and produced an extracellular 
brown pigment that caused discoloration of the medium. In contrast, colonies of J2552 
and JL32 were mucoid, white-creamy and opaque with no pigmentation of the medium. 
Upon preliminary experiments of catalase activity by adding a few drops of 3% H2O2 , 
both J2315 and 27 demonstrated marked evolution of gas compared with J2552 and JL 
32 that produced very little gas. To study the catalase activity of these four strains in 
planktonic and biofilm cultures at two different growth stages, the growth characteristic 
of each strain was established. For planktonic cultures, preliminary experiments with 
LB broth cultures were performed to determine that OD470 values 0.3-0.5 and 3.0-5.0 
corresponded to mid-logarithmic (mid-log) and early stationary phase, respectively (Fig. 
4.1). The doubling time for J2315 and JL27 was 2 hours in LB broth medium, while 
J2552 and JL32 grew faster with a doubling time of 30 minutes.
The growth curves of the bacterial strains J2315 and JL27 forming a biofilm could be 
divided into a lag phase, followed by logarithmic phase after 10 hours and ended in 
stationary phase after 20 hours. While for the bacterial strains of J2552 and JL32, the 
lag phase was followed by an logarithmic phase after 5 hours and ended in stationary 
phase after 18 hours (Fig 4.2a and b).
This enabled investigation and comparison of the catalase activity of the four strains of 
B. cepacia at mid-log and early stationary phases of planktonic and biofilm cells.








Fig 4.1. Growth of Burkholderia cepacia strains in 
planktonic culture in LB broth at 37°C.
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Fig. 4.2.a and b. Growth of Burkholderia cepacia as a biofilm 
on a membrane support on LB agar at 37°C.
(a) (♦ )JL 2 7  and (■ )  J2315 strains, and
(b) ( ^ ) J2552 and ( • )  JL 32 strains.
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4.2.2. Planktonic B. cepacia cells versus biofilm H 2O 2 susceptibility in mid-log and 
early stationary phase
In many bacteria, the response to oxidative stress varies according to growth phase 
(Loewen et al., 1985; Katsuwon and Anderson, 1992; Loewen, 1996; Vattanaviboon 
and Mongkolsuk, 2000). Also in recent work it was observed to be variable when cells 
are growing as planktonic or biofilm (Hassett et al., 1999a and b; Bolliger et al., 2001). 
The susceptibility of the four strains of B. cepacia, growing as biofilm or planktonic at 
mid-log and early stationary phase to the exposure of 5 mM H2O2 added extracellularly 
for 60 minutes was observed and results were recorded and expressed as percent 
surviving fraction. There was a significant reduction in surviving fraction of planktonic 
J2552 and JL32, but planktonic J2315 and JL27 were less susceptible. In all cases, 
survival increased in stationary-phase planktonic cultures when compared to survivals 
at mid-log phase. The planktonic J2552 and JL32 were killed after 60 minutes of 
exposure to H2O2 , with more than 4 log cycle decrease in survival at mid-log and 
stationary phase (Fig.4.3 and Fig 4.4). The planktonic J2315 showed a high survival 
rate at mid-log as well as early stationary phase, with less than 1 log cycle decrease in 
survival at mid-log phase (Fig. 4.5). The mid-log and early stationary planktonic cells of 
JL27 survived after 60 minutes exposure to 5 H2O2 with 1 log cycle decrease in 
survival respectively (Fig. 4.6).
For biofilm cells, the same pattern of susceptibility for the four strains was observed as 
in planktonic cells. Interestingly, biofilms of all cells were more susceptible at early 
stationary than mid-log phase, following 5 mM H2O2 exposure for 60 minutes.
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At early stationary phase biofilm cells of J2552 and JL32 strains were killed after 30 
and 45 minutes of exposure to 5 mM H2O2 , respectively, with a 3 log cycle decrease in 
survival (Fig. 4.3 and Fig 4.4). While at mid-log phase biofilm cells of both strains were 
killed after 45 and 60 minutes, respectively with more than a 4 log cycle decrease in 
survival (Fig. 4.3 and Fig. 4.4). The biofilm J2315 strain survived killing with 5 mM 
H2O2 , with less than one log cycle decrease in survival at mid-log and stationary phase 
after 60 minutes exposure (Fig. 4.5). As well, the biofim cells of JL27 were resistant to 
killing with 5 mM H2 O2 , but with a one log cycle decrease in survival after 60 minutes 
of exposure to H2O2 (Fig. 4.6).
In order to compare differences in susceptibility between planktonic and biofilm cells at 
mid-log and early stationary phase to killing with 5 mM H2O2 , the percent surviving 
fraction of J2315 and JL27 to H2O2 killing at 60 minutes of exposure were plotted for 
each strain separately. There were no significant differences in susceptibility of 
planktonic and biofilm cells of J2315 to 5 mM H2O2 at either, mid-log and early 
stationary phase (Fig. 4.7a). Biofilm cells of JL27 at early stationary phase were more 
susceptible than its planktonic counterpart (p < 0.05). While at mid-log phase of 
planktonic and biofilms there were no significant differences in susceptibility (Fig. 
4.7b)
4.2.3. Catalase expression by B. cepacia planktonic and biofilm cells at mid-log and 
stationary phase
Catalase specific activities have been determined to correlate the H2O2 sensitivity of the 
four strains to the level o f expressed catalase. This enzyme has been assayed from cell
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Fig 4.3. Susceptibility of planktonic and biofilm of B. cepacia 
J2552 to 5 mM H20 2 after growth to mid-log and early 
stationary phase. Samples were plated in triplicate for colony count 
and percentage survival was calculated relative to colony 
counts of untreated bacteria. Each point is the mean. SEM values 
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Fig 4.4. Susceptibility of planktonic and biofilm B. cepacia JL32 
to 5 mM H20 2 after growth to mid-log and early stationary phase. 
Samples were plated in triplicate for colony count and percentage 
survival was calculated relative to colony counts of untreated bacteria. 
Each point is the mean. SEM values were not shown because it is 






























Fig 4.5. Susceptibility of planktonic and biofilm B. cepacia 
J2315 to 5 mM H20 2 after growth to mid-log and early 
stationary phase. Samples were plated in triplicate for colony 
count and percentage survival was calculated relative to colony 
counts of untreated bacteria. Each point is the mean. SE values 
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Fig 4.6. Susceptibility of planktonic and biofilm B. cepacia 
JL27 to 5 mM H20 2 after growth to mid-log and early 
Stationary phase. Samples were plated in triplicate for 
colony count and percentage survival was calculated relative 
to colony counts of untreated bacteria. Each point is the mean. 
















Mid-log phase Early stationary phase
Fig. 4.7. Comparison of growth inhibition of planktonic 
cells and biofims of Burkholderia cepacia strains after 
60 minutes exposure to 5 mM H20 2. (a) B. cepacia J2315 
strain, and (b) B. cepacia JL27 strain.
Significant differences between cell survival of mid-log 
and stationary phase and of planktonic and biofilm 




lysates, not challenged with H2O2 , from biofilm and planktonic cultures at mid-log and 
early stationary phase. The results of specific catalase activity were consistent with the 
sensitivity of the four strains upon exposure to 5 mM H2O2 for 60 minutes. Generally, 
the specific catalase activities o f the planktonic cultures for the four strains were higher 
at stationary phase than mid-log phase On the contrary the catalase activity was reduced 
at the stationary phase of biofilm cultures of all four strains. The J2315 and JL27 
catalase activity was higher than J2552 and JL32 that were more susceptible to 5 mM 
H2O2 for 60 minutes (Table 4.1).
In J2315 planktonic cells, catalase was expressed at mid-log and early stationary phase, 
with maximal expression occurring during the transition to stationary phase. However, 
in J2315 biofilm cells, catalase activity was 2-fold higher at mid-log phase than early 
stationary phase cells. In JL27 planktonic cells the moderate catalase activity at mid-log 
phase also increased during transition to stationary phase, but in biofilm cells catalase 
activity at mid-log phase was 4-fold higher than early stationary phase (Table 4.1).
In J2552 and JL32 planktonic cells, catalase activities were very low at mid-log phase 
with a slight increase at stationary phase, however, in J2552 and JL32 biofilm cultures 
catalase activities were very much lower than in planktonic cultures from both mid-log 
as well as stationary phase (Table 4.1).
The isozyme profiles from the planktonic and biofilm cultures were determined with 
cell lysates from the two stages o f growth, mid-log and early stationary, by staining for 
catalase activity after separation on native PAGE gels (Fig. 4.8 and 4.9, respectively). It 
should be noted that the band intensity is not strictly proportional to the catalase activity 
of the band, which is a drawback this method shares with other negative stains






Strain mid-log early stationary
Catalase Catalase
activity ±SEM activity ±SEM
J2315 27 ±2.0 31 ±1.3
J2552 0.68 ±0.02 3.2 ±0.2
JL27 10 ±6.0 18 ±0.1
JL32 0.56 ±1.0 5.0 ±1.3
J2315 29 ±0.7 14 ±3.0
J2552 0.05 ±0.02 0.03 ±0.01
JL27 8.0 ±2.0 2.0 ±0.8
JL32 0.02 ±0.01 0.03 ±0.02
Table 4.1. Specific catalase activity of B. cepacia strains.
Each reading represents the mean ± SEM of three experiments. Specific catalase 
activity is indicated as unites per mg protein
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(Clare et al., 1984; Woodbury et al., 1971). J2315 and JL27 J2552 and JL32 appeared 
to contain only a single catalase, while JL32 demonstrated two bands of catalase 
activity only at mid-log phase. Enzymes with different gel mobility might be due to 
protein aggregates that cannot be resolved by native PAGE.
Gels of the planktonic J2315 and JL27 cells from mid-log and early stationary phase 
displayed one wide band of catalase at mid-log and stationary phase. For biofilm cells 
J2315 and JL27 produced the same single catalase band, at mid-log and early stationary 
phase, but with reduced intensities (Fig. 4.8 and 4.9). The catalase bands of the J2552 
and JL32 biofilm started to disappear at stationary phase (Fig. 4.9).
4.2.4. Cloning of a segment of KatE gene from B. cepacia J2315 and J2552 strains
As B. cepacia strain J2315 demonstrated a phenotype characteristic of high constitutive
catalase activity, while strain J2552 showed low catalase activity, a genetic approach 
was employed to clone and characterize the catalase gene katE from these two 
organisms. The strategy was to use PCR primers directed against conserved regions of 
the catalase gene to amplify an internal fragment of the catalase gene. To accomplish 
this, advantage was taken of the high homology between regions of katE o f Escherichia 
coli with catalase from different phyla (von Ossowski et al., 1991). Using the alignment 
of the primary structures of the KatE (HPII) proteins of E. coli and P. aeruginosa as a 
template (Fig. 4.10), degenerate oligonucleotides derived from the regions of homology 
between E. coli and P. aeruginosa katE gene were designed with a bias toward the high 
G+C codon usage of P. aeruginosa (West and Iglewski, 1988).
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V___________________ J  V___________________________ J
Early stationary phase Mid-log phase
Fig. 4.8. Detection of catalase activities in planktonic 
cell-free lysates from B. cepacia strains.
Extracts were from mid-log and early stationary phase 
and analysed by native PAGE followed by staining 
described in Methods.(l)J2315, (2) J2552, (3) JL27, 
and (4) JL32.
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v_____________________;  v____________________;
Mid-log phase Early stationary phase
Fig 4.9. Detection of catalase activities in biofilm 
cell-free lysates from B. cepacia strains.
Extracts were from mid-log and early stationary phase 
and analysed by native PAGE followed by staining 
described in Methods. (1) J2315, (2) JL32, (3) JL27, 
and (4) J2552.
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4.2.5. Comparison of amino acid sequence between E. coli and P. aeruginosa 
catalases to develop degenerative oligonucleotides
Comparison of the deduced amino acid sequence of the catalase HPII subunit from E. 
coli and P. aeruginosa revealed significant similarity between portions of HPII. The 
homologous sequence is presented in Fig 4.10. Identity and similarity percentages were 
obtained by pair-wise comparison of amino acid residues using the Blast facility 
provided on the NCBI website (http://www.ncbi.nlm.nih.gov) which revealed 58% 
identities and 70% similarities. The sites of homology were reverse transcribed into 
nucleotide sequence, using codon usage data (West and Iglewski, 1988) to design two 
degenerate oligonucleotides.
Genomic DNA from B. cepacia J2315 and J2552 were prepared as described in 
Methods 2.4.2. To amplify the katE gene in two strains of B. cepacia the following 
degenerate oligonucleotide (primer) pair was used: catl (5’-TTCGC G/C A G/C C G/C 
AAGTTCTACAC) and cat2 (5’-TT G/C CGGTT G/C AG G/C ACCAT). These 
primers predicted to bind 550 bp apart, and indeed 550 bp fragments were amplified for 
J2315 and J2552 (Fig. 4.11). The amplimers were designated as cat21 and cat22.
4.2.6. Cloning of 550 bp of katE gene in pGEM-T vector
In order to characterise the katE gene, cat21 and cat22 were cloned, amplified and 
sequenced. The gel-purified 550 bp amplimers were cloned into the multiple cloning 
site of the plasmid vector pGEM-T to produce pGEM-cat:21 and pGEM-cat:22, which
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Fig. 4.10. Box-shade ClustalW analysis of HPII catalase homologous sequence of E. coli 
and P. aeruginosa. Dashed lines represent gaps introduced to optimise alignments. 
Underlined amino acid sequences denoted sites of degenerative oligonucleotides catl and 
cat2.
J2315 J2552
Fig 4.11. Agarose gel analysis of PCR products B. cepacia 
J2315 and J2552. Lane M is 100 bp DNA marker.
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were then transformed into E. coli JM109 by heat shock. Transformants were recovered 
on selective LB agar containing 100 pg/ml ampicillin and those containing the 
recombinant plasmid were identified by blue-white colour selection. Successful cloning 
of an insert in the pGEM-T vector interrupts the coding sequence of the P-galactosidase, 
thus recombinant clones that contain 550 bp PCR fragment (cat21 or cat22) produced 
white colonies.
4.2.7. Restriction enzyme mapping of pGEM-cat:21 and pGEM-cat:22 DNA
The pGEM-T contains multiple restriction sites within the multiple cloning region. 
These restriction sites allow for the linearisation of the recombinant plasmid. 
Alternatively, a double-digestion may be used to release the insert.
The pGEM-cat:21 and pGEM-cat:22 plasmids were purified as described in Methods 
2.4.11. Plasmids were digested with Apa I and Pst I separately and in combination. The 
single digests linearized both pGEM-cat:21 and pGEM-cat:22 (Fig 4.12 and 4.13, 
respectively) and the digests were of the expected molecular weight (3.55 Kb). The 
double digests released 550 bp, cat21 and cat22 inserts from both of the pGEM-cat:21 
and pGEM-cat:22 (Fig. 4.12 and 4.13, respectively).
4.2.8. Sequence analysis of the 550 bp insert cat21
The cloned 550 bp fragment in pGEM-cat21 was amplified by PCR using the vector 
primer pair T7 and SP6 RNA polymerase promoters flanking the multiple cloning 
region within the a-peptide coding region of p-galactosidase. The amplified cat21
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1 2 3 4 5 6 M l M2
Fig. 4.12. Agarose gel analysis of restriction enzyme digests 
of pGEM cat:21. Lane 1 double digest with Pst I and Apa I, 
lane 2 single digest with Pst I, lane 3 single digest with Apa I, 
lane 4 undigested pGEM cat:21, lane 5 undigested pGEM-T 
vector, lane 6 digested pGEM-T vector with Pst I, lane Ml 
100 bp DNA marker, and lane M2 3kb DNA marker.
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Fig. 4.13. Agarose gel analysis of restriction enzyme digests 
of pGEM cat:22. Lane 1 single digest with Pst I, lane 2 single 
digest with Apa I, lane 3 double digest with Pst I and Apa I, 
lane 4 undigested pGEM cat:22, and lane M 100 bp DNA 
marker.
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fragment from pGEM-cat:21 was sequenced at the Department of Biology and 
Biochemistry University of Bath, using an automated DNA sequencing with d- 
Rhodamine terminator dye chemistry and FS Taq polymerase (PE Applied Biosystems). 
Figure 4.14 shows the alignment of the 550 bp amino acid sequence of HPII of B. 
cepacia J2315 strain with putative HPII amino acid sequence of E. coli and P. 
aeruginosa, which were used to design the degenerate primers.
BLAST analysis revealed that the primary sequence of catalase of B. cepacia J2315 is 
44% identical (58% similarity) and 44% identical (55% similarity) to the putative 
catalase sequences of E. coli and P. aeruginosa, respectively. However, BLAST 
analysis to other related bacteria revealed 90% identical (90% similarity) to catalase 
from P. fluorescens, 83% identical (88% similarity) to the catK P. aeroginosa PAOl 
strain, 81% identical (87% similarity) to the catalase from Xanthomonas campestris, 
85% identical (77% similarity) to the catalase from Vibrio cholerae and 58% identical 
(72% similarity) to the catalase from Bacillus anthracis.
4.3. Methionine sulfoxide reductase (MsrA) in B. cepacia strains
The methionine sulfoxide reductase (MsrA) is a ubiquitous antioxidant enzyme found in 
a wide variety of organisms that has the ability to reverse the inactivation of many 
proteins due to the oxidation of critical methionine residues during oxidative stress. 
MsrA catalyses the reduction of methionine sulfoxide [Met(O)] residues to methionine. 
The oxidation of a specific methionine residue may occur by the activity of hydrogen 
peroxide, hydroxyl radicals, superoxide anions (Brot et al., 1981) and peroxynitrite
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(St.John et al., 2001). In many cases, the oxidation of a specific methionine residue 
leads to the loss of biological activity of certain proteins required for cell viability. Thus 
the ability to reduce Met(O) residues in proteins is important for the survival of E. coli 
(Moskovitz et al., 1995), yeast (Moskovitz et al., 1997) and Mycobacterium 
tuberculosis (St. John et al., 2001).
In vitro experiments revealed that the msrA gene is also in the class of genes that are 
expressed in a growth-dependent manner, since Moskovitz et al. (1995) showed that the 
synthesis of MsrA protein increased about threefold during the transition of E. coli cells 
to stationary phase.
So the hypothesis was whether such a repair system exists in B. cepacia strains in 
parallel to catalase to protect themselves from the toxic effect of reactive oxygen 
intermediates.
4.4 Results
4.4.1 Methionine sulfoxide reductase A, activity assay from planktonic B. cepacia 
strains
The pellets from planktonic cells of the mid-log and stationary phase of B. cepacia 
strains J2315, J2552, JL27 and JL32 were assayed for MsrA activity at the Weil 
Medical college of Cornell University, New York. No MsrA activity was detected at 
either mid-log nor at stationary phase from the four strains of B. cepacia. The substrate 
JV-acetyl-L-[ H] methionine sulfoxide was not reduced in the presence of 15 mM DTT 
or a thioredoxin regenerating system, indicated by the lack of radioactive product N-Ac- 
L-[3H] methionine.
ANTIOXIDANT ENZYMES OF B. cepacia STRAINS 115
E . c o l i  1
P . a e r u g i n o s a  1
B . c e p a c i a  J 2 3 1 5  1
E . c o l i 6 1  Bq T
P . a e r u g i n o s a 6 1  g T M ' - : M a S W W n i | i W E N!  B S B j B a S H T B ; A s  v 8 t c H
B . c e p a c i a  J 2 3 1 5 5 7  HV T g j - g T  J Y ^ S g  g E I ib n h b I aB M W kM v B B S f e  b  8 I K N g D P
★
E . c o l i  1 2 1
P . a e r u g i n o s a  1 2 1  
B . c e p a c i a  J 2 3 1 5 1 1 KgVTl lYSHM TNggVTH
NQQDS
E . c o l i  1 8 1
P . a e r u g i n o s a  1 8 1  
B . c e p a c i a J 2 3 1 5  1 7 4 - - V L N R N P
Fig.4.14. Box-shaded ClustalW analysis of HPII catalase seqment isolated from B. 
cepacia J2315 strain with homologous sequence of E. coli and P. aeruginosa. 
Dashes represent gaps introduce to optimise alignments, conserved residues are 





Oxidative stress can be functionally defined as an excess of prooxidants in the living 
cell. Active oxygen molecules have been shown to cause damage to DNA, RNA, 
proteins and lipids as discussed previously. Active oxygen intermediates are produced 
as an inescapable by-product of normal aerobic metabolism, and their production is 
further enhanced by exposure to certain environments or by dietary or disease 
conditions. Under certain conditions the concentration of reactive oxygen species rises 
to a level that overwhelms the basal level of scavenging capacity of the cell, giving rise 
to an oxidative stress condition. Bacteria respond to a variety of stresses and undergo 
derepression of a set of globally regulated genes (Gottesman, 1984). Two of the well 
known responses to oxidative stress are the peroxide stress response and the superoxide 
stress response, that are induced under increased influx of H2O2 or the superoxide 
radical O2- , respectively (Farr and Kogoma, 1991). Interestingly, these two oxidative 
stress responses are different, since a large volume of evidence has accumulated which 
indicates that the peroxide and superoxide stress responses are distinct. For example, 
cells pretreated with H2O2 and cells preinduced with O2- generators do not develop 
cross-resistance (Farr et al., 1985). Similarly, KhC^-pretreated cells reactivate H2 O2 - 
damaged phage but not 0 2 ~ -damaged phage, whereas O2 -pretreated cells reactivate 
02~ -damage phage but not H2O2 -damaged phage (Farr and Kogoma, 1991). For the 
most part, proteins induced with H2O2 are different from those induced under 0 2 ~ 
generating conditions (Loewen et al., 1981). In addition, it was demonstrated lately that 
other types of stress, such as heat shock and starvation, could also induce some proteins
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that are induced by oxidative stress (Farr and Kogoma, 1991). In vivo, oxidative stress 
can be brought about by addition of H2O2 or superoxide anion generators, such as 
paraquat (Farr and Kogoma, 1991) and a mixture of hypoxanthine and xanthine oxidase 
(Smith eftf/., 1999).
Genetic mapping studies revealed the presence of two independent species of catalase in 
Escherichia coli, the loci katE (Loewen, 1984) and KatF  (Loewen and Triggs, 1984) 
affect the synthesis of an apparently monofunctional catalase which was characterized 
as hydroperoxidase II (HPII), while the locus katG affects the synthesis of the 
bifunctional iso-enzyme pair labeled HPI-A and -B  that possess both catalase and 
peroxidase activity and generally called SOD. As a member of the LysR family of 
autoregulators, OxyR responds to the increasing oxidant levels inside the cells and 
activates the transcription of katG along with several other H2O2 inducible genes (Storz 
and Targalia, 1992). In contrast, synthesis of the HPII catalase is not induced by H2O2 , 
but is dependent on RpoS, a stationary phase-specific sigma factor that is itself subject 
to complex transcriptional and post-transcriptional controls (Loewen and Triggs, 1984; 
Mulvey et al., 1988; Schelhom and Hassan, 1988; Fang et al., 1992; Mulvey et al., 
1990; Loewen and Hengge-Aronis, 1994; Loewen, 1996; Robbe-Saule et al., 2001). 
Oxidative stress is strongly implicated in the CF lung where the inflammatory response 
is dominated by neutrophils, however, B. cepacia strains isolated from CF patients, 
especially those of genomovar III, are strong catalase and SOD producers (Lefebre and 
Valvano, 2001). This indicates that B. cepacia resistance to oxidative damage may play 
a role in the infectivity and persistence of this opportunistic pathogen in the CF lung. 
Infection of CF airways with B. cepacia is associated with a worse prognosis than
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infection with P. aeruginosa (Hutchison and Go van, 1999). Moreover, differential 
pathogenicity among strains of B. cepacia has been observed in CF patients, although 
the basis of this differential pathogenicity amongst genomovars is unknown.
Smith et al., (1999) and Pacelli et al., (1995) showed that NO potentiated toxicity O2-- 
mediated killing of B. cepacia and E. coli, respectively, and this killing was abolished 
by catalase but not SOD. Exogenously added SOD did not show any protective role in 
B. cepacia (Smith et al., 1999). These data suggest that catalase, but not SOD, is 
responsible for the resistance of B. cepacia to oxidative killing in vitro. Moreover, some 
strains of B. cepacia showed resistance to 5 mM of H2O2 while others were more 
susceptible (Smith et al., 1999). We hypothesized that since catalase activity is likely 
important for the virulence and pathogenicity B. cepacia in the CF lung, and that there 
are differences in pathogenicity among different strains of the B. cepacia, it may be 
possible that this is due to differences in the expression of expressed catalase levels 
and/or to differences in its activity.
Till this date, the catalase enzyme in B. cepacia has not been systematically 
characterized, except for the recent study of Lefebre and Valvano, (2001). In this study 
four strains of B. cepacia were selected to investigate their catalase expression and 
activity, which may contribute to bacterial survival and persistence in infection of the 
CF lung and airway. In addition the survival rate of the four strains as determined 
following challenge with H2O2 at a concentration equal or higher than those normally 
found in vivo. The strains used in this study were: B. cepacia strain J2315 which is a 
highly virulent strain belonging to genomovar III, highly transmissible and has been 
associated with cepacia syndrome, B. cepcia strain J2552, which is an environmental
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isolate that belongs to genomovar I, B. cepacia strain JL 32 which is a CGD isolate and 
B. cepacia strain JL27 that belonges to genomovar III (Smith et al., 1999). In order to 
gain a better understanding for the role of catalase in resistance of B. cepacia to H2O2 
during infection to CF lung, catalase activity and expression were investigated in the 
biofilm model of bacterial cultures on the surface a filter membrane and compared with 
planktonic cultures. Bacterial biofilms not only exist widely in nature (Costerton et al., 
1995), but also in clinical settings, especially in patients with CF (Gilbert and Brown,
1995), where they show different physiological properties in their response to 
environmental influence compared with their planktonic models. Previous studies 
revealed marked changes in virulence factor production in B. cepacia, when grown 
under nutrient limitations in a chemostat model resembling the biofilm mode of growth 
(McKenney and Allison, 1995). Also it was demonstrated that there is a marked 
difference in the oxidative response in the biofilm of P. aeruginosa (Hassett et al., 
1999a and 1999b) and Nitrosomonas europaea (Wood and S0rensen, 2001) relative to 
planktonic growth.
B. cepacia J2315 strain possessed a single catalase, as revealed by electrophoretic 
analysis, which was expressed at mid-log and at early-stationary phase in planktonic as 
well as in biofilm models. In contrast, catalase activity was strongly growth-dependent 
in planktonic B. cepacia JL27, which also possessed one catalase, and its activity 
increased as the planktonic cells went from exponential phase to early stationary phase. 
In spite of lack difference of band intensities in native gels, the highest catalase specific 
activity from both stains, J2315 and J2552, were obtained in early stationary phase of 
planktonic cells. The electrophoretic analysis of J2315 and JL27, with only one catalase
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class, matched the catalase profile detected from strains B. cepacia genomovar III in a 
recent study of Leferbe and Valvano, (2001) where also one catalase class was detected 
from genomovar III. While closely related species such as P. aeruginosa, P. putida, P. 
syringae and Xanthomonas sp. possess multiple catalase isozymes (Brown et al., 1995; 
Katsuwon and Anderson, 1992; Mongkolsuk et al., 1996).
The B. cepacia stains J2552 and JL32 possessed also one electrophoretotype catalase, at 
stationary phase, while at mid-log phase, only JL32 showed another band of catalase 
isozymes, one of which might correspond to a larger protein aggregate. However, the 
catalase specific activities were less than those from J2315 and J2552, but increased in 
planktonic cells entering stationary phase. In addition, the resistance to superoxide 
killing of the planktonic cells of the four strains matched their specific catalase activity, 
in parallel with bacterial growth. In the past decade, the regulation of the catalase levels 
in a number of other microorganisms has been studied. It appeared that the two main 
factors influencing the catalas levels in the majority of bacteria are H2O2 and the 
stationary phase response (Loewen, 1997). Oxygen levels have been indicated as a third 
general factor regulating catalase synthesis in some organisms, like Bacteroides fragilis 
(Rocha and Smith, 1995), Xanthomonas orzae (Loprasert et al., 1996) and 
Lactobacillus sakei (Hertel et al., 1998). In addition, there are some regulatory 
mechanisms that appear to be unique to individual organisms. These include carbon 
limitation repression (Rocha and Smith, 1997), superoxide induction (Loprasert et al.,
1996), repression in stationary phase (Bishai et al., 1994) and cell density repression 
(Ma and Eaton, 1992; Ansley et al., 1995).
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The catalase expression in the four strains of B. cepacia used in this study increased 
when planktonic cells entered the stationary phase. However, activity was not totally 
depressed at mid-log phase, in highly active strains like the J2315 and JL27. This might 
indicate that the catalase is constitutively expressed in these strains.
The catalase expression of B. cepacia J2315, J2552, JL27 and JL32 may raise the 
question of whether catalase from these strains is under the control of the stationary 
phase sigma factor RpoS. RpoS homologues, also known as KatF, have been found in a 
number of bacteria, but most work on the RpoS regulon has been carried out in 
Escherichia coli. RpoS plays a key role in the survival of bacteria during starvation or 
exposure to stress conditions and is required for the expression of many genes in 
stationary phase (Ishihama, 1997; Loewen et al., 1998; Hengge-Aronis, 1999). During 
rapid growth in laboratory conditions, E. coli contains very little RpoS, which becomes 
abundant at the onset of the stationary phase. However, it was shown that RpoS 
expression was also induced during exponential (Log) phase upon exposure to certain 
stress conditions (Ishihama, 1997; Loewen et al., 1998; Hengge-Aronis, 1999). The 
cellular level of RpoS is regulated at the level of transcription, translation and protein 
stability. Currently it is predicted that at least 50 genes are subject to RpoS regulation in 
E. coli (Loewen, 1998; Tao et al., 1999) amongst which is the katE gene. Induction of 
katE in sationary phase suggested a role in long term survival under starvation and 
stress conditions. As the catalase expression from highly active strains of B. cepacia 
used in this study, especially J2315, were observed at mid-log as well as early stationary 
phase, this might indicate that the catalase gene is not regulated by levels of RpoS at 
different growth stages.
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In comparison to planktonic cells, biofilm cells of B. cepacia strains J2315, J2257, JL27 
and JL32, showed reduced catalase activity in mid-log phase, and further reduction was 
observed on entering stationary phase. Also the susceptibility of strains to H2O2 was 
increased in biofilm cultures when compared with planktonic ones.
These data indicated that biofilm growth was indeed affecting the oxidative response in 
B. cepacia strains. One likely possibility is the direct effect of environmental factors, on 
gene regulation, that may cause the different response to oxidative stress response in B. 
cepacia strains. The most obvious environmental factors that could affect catalase 
expression in biofilms and potentially account for this difference are iron, oxygen 
availability and H2O2 production. Oxygen availability is a possible explanation for the 
depressed levels o f catalase in biofilm cutures of B. cepacia strains. It is worth noting 
that catalase activity and resistance of biofilm cells, were higher at mid-log phase where 
the number of cells is less and oxygen availability is greater than at stationary phase. 
Other studies have shown that oxygen tension is reduced in bacterial biofilms 
(Costerton et al., 1995; Xu et al., 1998) and the endogenous generation of H2O2 also 
will be reduced and consequently the requirement for elevated catalase levels will be 
minimal.
This result is consistent with the previous studies by Hassett et al., (1999a and b.) who 
observed that catalase activity (KatA) of P. aeruginosa biofilm cells was considerably 
lower than that in planktonic cells, but the resistance of biofilm P. aeruginosa to H2O2 
was greater than their planktonic counterparts. Frederick et al., (2001) observed that 
depressed catalase activity from biofilm cells of P. auroginosa was due to iron 
limitation and there was no evidence of influence oxygen limitation. In a recent study,
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Wood and Sorensen (2001) showed that catalase levels from biofilm cells of 
Nitrosomonas europaea were elevated over 50% when compared with planktonic cells. 
The increase in catalase activity was attributed to the response of cell density-dependent 
gene, which expression resulted in the accumulation of homoserine lactone (HSL) 
within the constrained intercellular spaces of biofilms. However, Wood and S0rensen 
showed no evidence for a role of HSL-mediated gene regulation of catalase from 
Nitrosomonas europaea (Wood and S0rensen. 2001).
Previous studies showed evidence that bacteria in the lung grow as a biofilm and under 
iron-limited (Brown et al., 1984; Haas et al., 1991), oxygen-starved conditions 
(Costerton et al., 1995; Xu et al., 1998) and in immediate vicinity to increased 
concentrations of H2O2 produced from stimulated neutrophils. In this study, biofilm 
cells of B. cepacia strains were not exposed to iron starvation and their catalase 
activities were low as well as their resistance to oxidative stress were attenuated. 
Accordingly, resistance of B. cepacia strains to oxidative stress cannot, at this point, be 
completely attributed to differences in catalase activity. An alternative explanation 
might be that cells grown in liquid are exposed to a different oxidizing environment 
from those growing as a biofilm, resulting in an altered expression of stress enzymes or 
there could be direct effects of environmental factors on the enzymes themselves. 
Another possibility is that catalase genes from B. cepacia may be modulated by other 
regulatory genes not yet identified.
The ability of B. cepacia strain to persist and survive intracellularly despite the 
oxidative stress in the CF lung may be attributed in part to the antioxidant defence 
mediated by catalase, while the antioxidant enzyme MsrA likely plays no role in the
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oxidative response. In addition, there was some variation of catalase activity among 
strains of B. cepacia, which may explain, in part, the variation in virulence among 
strains of B. cepacia. Other studies detected differences in the pathogenic stimulatory 
activities of the lipopolysaccharide (LPS) from B. cepacia, P. aeruginosa and 
Stenotrophomonas maltophilia which could explain the different pathogenic sequelae 
observed with lung infections caused by these three organisms in CF patients (Shaw et 
al., 1995; Demko et al., 1998; Zughaier et al., 1999).
In summary, the resistance of B. cepacia strains to toxicity by reactive oxygen species 
may be explained, at least in part, by their ability to produce catalase antioxidant 
enzyme. The level of expression of catalase for the most virulent strain, J2315, was 
detected at mid log and early stationary and its specific activity increased in the cells 
entering stationary phase. This may be important in vivo as it would provide a higher 
level of protection to this strain able to establish a chronic infection where the bacteria 
would likely be under physiological conditions similar to the late stationary phase of 
growth. Alternatively, altered resistance of B. cepacia strains growing in biofilm mode, 
resembling those colonizing the airways, to oxidative killing, suggested that there might 
be another virulence factor(s) contributing to their resistance and ability to induce 
inflammation in the CF lung.
Cloning and analysis of a deduced sequence of the structural gene encoding HPII 
catalase could be used to isolate and sequence the regulatory genes upstream, or could 
be used as a probe to identify variations in expression of catalase product from other
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strains of B. cepacia. The catalase gene from J2315 and J2552 were selected to be 
isolated because their catalase activity, as well as their resistance to H2O2, were 
different. The first step to isolate catalase from B. cepacia J2315 and J2552 was to find 
sequences of homology after pair alignment of E. coli and P. auroginosa. As the 550 bp 
segments, we predicted to be part of the catalase gene, were successfully isolated and 
cloned from the two selected strains, only the deduced segment from J2315 were 
sequenced. The HPII deduced segment from the nucleotide sequence of katE of J2315 
showed a great degree of similarity with other catalase from related bacteria. Several of 
the conserved amino acids in B. cepacia J2315 catalase correspond to residues of amino 
acids in that play a role in active site of the E.coli HPII and in binding the protoheme. In 
particular, one of the three amino acid residues highly conserved in the active site of the 
enzyme of E.coli HPII and had its counterpart in B. cepacia J2315, was Asn-201. 
Another one residues of the seven highly conserved residues on the proximal side of the 
heme in the of E. coli HPII sequence Phe-206 was also conserved on the sequence of 
the B. cepacia J2315 catalase sequence. Finally, one of the four conserved amino acids 
involved in NADPH binding in the HPII sequence of E. coli, were also found in the 
catalase segment o f B. cepacia J2315 strain which is the Lys-294 (vonOssowski et al., 
1991). From these data, we can conclude that the cloned segment contains the gene 
coding the catalase HPII catalase of B. cepacia J2315. The cloning and the expression 
of B. cepacia katE gene could enable biochemical characterization of protein structure 
and function.
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5. General Discussion
Understanding host-pathogen interactions and selective pressures produced by 
inflammation of the respiratory tract in the CF airway is an extensive goal of cell 
biology to monitor the leading cause of morbidity and mortality in CF. The 
characteristic feature of the CF lung disease is the inability of the host to clear the 
initial colonization and infection of the airways despite an intense inflammatory 
response. An influx of neutrophils and macrophages and the secretion of pro- 
inflammatory cytokines such as IL-lp, IL-8 and TNF-a characterize this 
inflammatory process. Proteases, oxidants and a-defensins are released from 
inflammatory cells and contribute further to tissue destruction. DNA from lysed 
neutrophils, epithelial cells and bacteria increase the viscosity of airway secretions, 
leading to further impairment of mucociliary function. Exhaled air from patients with 
CF contains less nitric oxide (NO) than that from normal controls, indicating 
increased metabolism of NO or decreased production due to down regulation of 
inducible nitric oxide synthase (Kelley and Drumm, 1988; Grasemann et al., 1997). 
The respiratory epithelial cells are a major source of iNOS and NO in the lung where 
iNOS is expressed constitutively. The deficiency of NO in CF epithelia may 
contribute, in part, to the susceptibility of these patients to bacterial colonization. 
Accordingly, the question arises: How and why is iNOS expression down 
regulated in CF respiratory epithelium? .
In vitro as well as in vivo studies suggested that CFTR may be involved in 
maintaining the antioxidant homeostasis of the pulmonary epithelial lining fluid, and
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a mutation in CFTR could make the CF lung more susceptible to oxidative stress 
(Gao et al., 1999; Velsor et al., 2001). The oxidative environment is created by the 
inflammatory response and from the infectious agents. In many systems, the presence 
of oxidative stress increases cytokine-mediated iNOS expression (Kuo et al., 1997), 
and more interestingly, other studies demonstrated that reactive oxygen intermediates 
induce activation of NF-kB, a transcriptional factor essential for the expression of 
iNOS (Hoare et al., 1999). However, oxidants, including H2O2 , are known to activate 
PI 3-kinase pathway (Shaw et al., 1998; Sonoda et al., 1999). In many studies it was 
demonstrated that inhibition o f PI 3-kinase is necessary for the expression of iNOS 
(Wright et al., 1997; Park et al., 1997; Pahan et al., 1999). It is conceivable that in 
CF, high oxidative stress may activate PI 3-kinase, which in turn downregulates 
iNOS expression. This hypothesis was justified by activating PI 3-kinase from 
human A549 respiratory epithelial cell line via IL-13, which reduced NO production. 
Cytokine-stimulated A549 cells expressed elevated levels of NO compared with 
unstimulated cells that expressed minimal constitutive NO. There are a number of 
studies that support the view that PI 3-kinase activity down-regulates iNOS and that 
suppressors of iNOS need to activate PI 3-kinase in order to inhibit iNOS 
transcription and /or activity. Interleukin-13 has been shown to inhibit iNOS 
expression from A549 cell line (Berkman et al., 1996) but this work is the first to 
provide evidence for the involvement of the activity of PI 3-kinase. The use of PI 3- 
kinase inhibitors, wortmannin and LY249002, restored NO levels in cytokine- 
stimulated A549 pretreated with IL-13. This indicated that IL-13 inhibited NO in 
A549 indirectly by its ability to activate PI 3-kinase in A549 cells. However, other
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studies demonstrated an alternative way by which IL-13 can inhibit NO expression. 
IL-13 was shown to up-regulate arginase, another enzyme that utilizes the iNOS 
substrate L-arginine, and thus reduces NO production (Chang et al., 2000; 
Rutschman et a l , 2001). However, arginase activity was not detected from cytokine 
stimulated A549 cells pretreated with IL-13. This might eliminate the possibility for 
IL-13-inhibited NO production via arginase. Accordingly, inhibition of NO from 
cytokine stimulated A549 inhibition pre-treated with IL-13 was through the 
activation of PI 3-kinase per se.
These data show evidence which implicate PI 3-kinase-dependent signaling in the 
regulation of iNOS activity in CF human respiratory epithelial cells. However, it is 
worth emphasising that experiments investigating the regulation of NOS by PI 3- 
kinase have used many different cell models, and accordingly the interaction of PI 3- 
kinase with iNOS may exhibit tissue-specific regulation.
If iNOS expression in bronchial epithelium of CF patients was shown to be 
deficient, what difference does it make? Nitric oxide, expressed in higher 
concentration from activated iNOS, is a simple molecule that has been implicated in 
a vast array of physiological functions, including vasoregulation, neurotransmission 
and immune regulation. Nitric oxide and its oxidative by products, RNS, inhibit 
microbes in a manner that is similar to the mechanisms by which RNS inhibit 
mammalian target cells (Nathan and Hibbs, 1991). Most importantly, during an 
inflammatory response NO, or RNS, can be produced concurrently with superoxide 
anions, or ROS, in nearly equimolar amounts and can generate the particularly 
destructive product, peroxynitrite (OONO-) (Zhu et al., 1992). Smith et al., (1999)
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demonstrated the synergistic effect of NO with reactive oxygen species to eradicate 
one of the most important pulmonary pathogen in CF B. cepacia in vitro. So, 
deficiency of NO may contribute partially to enhanced susceptibility of CF patients 
to respiratory tract infections. So, since CF disease involves organs other than the 
respiratory tract, why is respiratory infection the major concern? In patients with 
cystic fibrosis, respiratory infection is the major cause of morbidity and mortality. 
With the development of treatments for intestinal obstruction and pancreatic 
insufficiency, patients typically survive beyond infancy, and at some point, virtually 
all patients develop chronic bacterial infection, abnormal airway secretions and 
airway inflammation (Pilewski and Frizzeill, 1999). This explains why lots of 
researchers aim to study the interaction between infection, inflammation and 
pulmonary function in CF patients. Common bacterial pathogens that infect the CF 
lung include Staphylococcus aureus, Haemophilus influenzae, P. aeruginosa and B. 
cepacia.
Infection with such opportunistic bacteria indicates the milieu of the lung of CF 
patients provides a favorable niche for bacterial infection. Among all, the most 
important pathogen which has emerged recently is infection with B. cepacia. So, 
why is infection with B. cepacia problematic in CF patients? Burkholderia 
cepacia is an extremely diverse class of bacteria, and the taxonomy has evolved to 
accommodate the enhanced understanding of the new genus within which it has been 
placed (Yabuuchi et al., 1992). Infection with B. cepacia strains, typically acquired 
late in the lifetime of CF patients, is most of the time preceded by infection with P. 
aeruginosa (Riedel et al., 2001). Apart from acquisition from the natural habitat,
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patient-to patient transmission and indirect nosocomial acquisition from 
contaminated surfaces have caused several outbreaks within and between regional 
CF centres (Govan and Deretic, 1996). Among the key strategies of B. cepacia to 
persist in the CF lungs resistance to phagocytic killing and invasion of epithelial 
cells, intrinsic resistance to a broad range of antibiotics (Tummler and Kiewitz, 
1999) as well as its resistance to epithelial-derived antimicrobial substances (Baird et 
al., 1999) are likely important. Moreover, differential pathogenicity among strains 
within the complex has been observed in CF patients. Colonization with strains of B. 
cepacia may range from chronic asymptomatic carriage to a rapidly fatal decline in 
lung function. Approximately, 80% of B. cepacia clinical isolates from Canada are 
from genomovar III, the most highly transmissible strains also belong to this 
genomovar, which is also associated with a higher mortality rate than other members 
of the complex (Speert et al., 2002). So, why do different genomovars of B. 
cepacia complex strains elicit different disease progression? Genomovars are 
phenotypically similar but genotypically distinct groups of strains that show low 
level o f DNA hybridization. It was recently demonstrated that differential persistence 
occurred among genomovars of B. cepacia complex in a murine model of pulmonary 
infection (Chu et al., 2002), however, details of which virulence factors were related 
to these differences were not described. Strains of B. cepcia complex produce a 
number of potential virulence factors, as mentioned in Introduction, and three 
markers have been predominantly found B. cepacia genomovar III associated with its 
transmissible isolates, including cable pili (Sun et al., 1995), which have been shown 
to mediate adherence to respiratory mucin (Sajjan et al., 1995); an open reading
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frame with homology to transcriptional regulators termed the B. cepacia epidemic 
strain marker, but its function is not well characterised (Mahenthiralingam et al., 
1997); and a hybrid of insertion sequences IS402 and IS1356 (Tyler et al, 1996). Yet, 
up till this time there is no evidence to suggest that some strains are more virulent 
than others. W hat about the setting of the CF lung? Many reports described the 
relationship between the defect in CFTR function and the increased susceptibility of 
CF lung to infection (Pilewski and Frizzell, 1999). The unique setting of the CF lung 
and airways may contribute to the possible escape of B. cepacia from oxidative 
killing. Moreover, it was shown by Isles et al. (1984) that differences in clinical 
features of pulmonary infection with strains of B. cepacia are related to differences 
in the underlying clinical conditions of the lung prior to infection or alternatively to 
infection by different strains. As mentioned earlier, recruitment of neutrophils to the 
site of infection is associated with a release of reactive oxygen species. In a recent 
study by Lefebre and Valvano (2001), seven out of 11 strains displayed high-level 
survival after H2O2 treatment in vitro which had a bifunctional catalase/peroxidase. 
These isolates, including genomovar III strains, showed different levels of resistance 
to intracellularly generated O2 and were correlated with detected levels of SOD 
activity. However, differences in survival to extracellular O2 were not detected. 
Furthermore, a recent study showed that nitric oxide acts synergistically with 
reactive oxygen species to kill B. cepacia in vitro (Smith et al., 1999) and suggested 
that persistence of B. cepacia in CF patients may be attributed to the defect in the 
iNOS activity in these patients (Kelley and Drumm, 1998). In another study, the 
presence of B. cepacia infection involved in CGD patients, whose neutrophils do not
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express an oxidative respiratory burst (Speert et al., 1994), supports the proposal that 
reactive oxygen and nitrogen species both can eradicate the B. cepacia infection. 
Also Smith et al., (1999) demonstrated that catalase from a number of tested B. 
cepacia strains and not SOD was able to abolish peroxynitrite killing. Then the 
attractive hypothesis that B. cepacia strains may vary in their catalase expression 
stemmed from a precedent observation of Smith’s study in which preliminary data 
showed variations in resistance of different strains of B. cepacia to killing by H2O2 , 
and when synergies with NO. The question then comes, Are there differences in 
expressed catalases from B . cepacia strains? First of all it was necessary to 
establish the difference in the catalase expression and resistance to H2O2 . In this 
study, four different strains from B. cepacia complex were investigated, differences 
in catalase specific activities where determined and the B. cepacia JL27 and J2315 
strains, belonging to genomovar III was found with highest catalase activity, and 
highest resistance to oxidative killing with H2O2 compared to the other strains J2552 
and JL32. To understand better catalase expression, and resistance of B cepacia 
strains to killing by H2O2 , B. cepacia were grown on a membrane surface resembling 
biofilm culture. It is now widely accepted that infections of soft tissues, bacteria 
grow as biofilms and such a clinical setting is very important, especially in CF 
patients (Gilbert and Brown, 1995). Biofilms may be regarded as adherent 
microcolonies, forming functional association o f cells embedded within an 
exopolysaccharide. Growth in this manner is clearly of advantage to bacterial cells 
living within a harsh environment since bacterial cells can persist in spite of 
antimicrobial therapy (Brown and Williams, 1985) and immune response (Anwar et
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al., 1983). Most importantly, genetic studies demonstrated variations in gene 
transcription in planktonic and biofilm-associated phases of the bacterial life cycle 
(Watnick and Kolter, 2000). In Gram-negative microbial biofilm gene expression of 
certain virulence factors is in a cell-density dependent manner. This form of gene 
regulation is widely known as quorum sensing (QS). Thus, during biofilm growth 
bacteria may express many stationary phase specific genes, of such is the 
mono functional catalase gene. We thought that biofilm B. cepacia might express 
catalase in higher concentrations resembling planktonic cells at stationary phase. 
Unfortunately, the catalase activity and resistance of biofilm B. cepacia strains were 
reduced and became more susceptible to H2O2 compared with planktonic cells. 
However, while catalase was implicated as an important factor in resistance to H2O2 
lethal affect, other factors seemed critical in controlling catalase expression from B. 
cepacia strains in biofilms.
As there is no doubt the contribution of catalase to protect strains of B. cepacia from 
damage caused by reactive oxygen species in CF lung, other environmental factors 
that may affect regulation of expression of catalase should be taken into 
consideration. Such environmental factors like iron availability and environmental 
acidity (Olson, 1993; Foster, 1999) if vary during infection may be in the favour of 
the pathogen.
Are there any other virulence factors that may contribute to the resistance of B. 
cepacia phagocytic oxidative killing? The mechanisms by which intracellular 
pathogens resist killing by macrophages include inhibition of phagosome-lysosome 
fusion, escape into the cytoplasmic compartment and resistance to reactive oxygen
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intermediates and lysosomal enzymes (Kaufmann, 1993). The intracellular B. 
cepacia cells were observed in infected macrophages as well as in respiratory 
epithelial cells, enclosed in membrane vacuoles (Bums et al., 1996). This indicates 
that the B. cepacia does not need to escape into cytoplasmic compartment to survival 
since it can inhibit the antimicrobial response of macrophages. In addition to SOD 
and catalase, B. cepacia strains produce melanin-like pigment, which may act as a 
scavenger of superoxide radicals (Zughaier et al., 1999). In addition it was observed 
that engulfment of B. cepacia by alveolar macrophages was reduced in the presence 
of lipase produced by B. cepacia cells (Straus et al., 1992). Recently, it was shown 
that B. cepacia produced elevated levels of lipase under oxygen-depleted conditions, 
which may help cells to evade phagocytic phagocytosis during the host responce 
(McKenney and Allison, 1995).
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6. Conclusion and future work
In this project, it has been shown for the first time that modulation of the 
cytokine activated iNOS enzyme in pulmonary epithelial cells by the signaling 
enzyme PI 3-kinase. In addition, the anti-inflammatory cytokine IL-13 can 
activate this signaling enzyme to down-regulate cytokine stimulated iNOS 
activity. It was demonstrated that modulation of cytokine-stimulated iNOS from 
respiratory epithelial cells was not through the activation of arginase, which may 
compete with iNOS for the common substrate L-arginine.
An important arena for the ability of the PI 3-kinase to mediate iNOS activity is 
the CF pulmonary epithelium. Increased susceptibility of CF patients was 
contributed to the absence of iNOS expression from respiratory tract, thus 
deregulation of the PI 3-kinase or using a selective PI 3-kinase inhibitor in CF 
may restore iNOS activity. By activating iNOS in the airway epithelium, levels 
of NO may be restored to potentiate reactive oxygen intermediates to terminate 
respiratory infectious bacteria is the main cause of lung dysfunction and high 
mortality and morbidity rate among CF patients.
In view of the PI 3-kinase results, there is much to be done to convert these 
initial findings in simple system into a more cogent understanding of the role of 
signaling and iNOS expression in CF physiology and disease. This includes:
• Assay for the PI 3-kinase accumulation in cytokine-stimulated A549 after 
treatment with IL-13, to further support that IL-13 modulation to cytokine 
stimulated iNOS is via PI 3-kinase.
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• Detection of the ability of IL-13 to modulate NF-kB and activate STAT6 in 
A549 respiratory cell line.
• Assay for iNOS activity from primary respiratory cell line transfected with CF 
gene, after cytokine stimulation and IL-13 treatment. This may explain if PI 3- 
kinase could modulate iNOS expression in CF lungs.
• Develop an oxidative stress system in a respiratory epithelial cell line to detect 
PI 3-kinase activity as well as activation of NF-kB, which are crucial event in 
the modulation of iNOS expression.
Another axis to combat respiratory infections in CF patients is to identify and 
characterize virulent factors that may attribute to the pathogenecity of the most 
troublesome infecting bacteria B. cepacia. The catalase activity, which enables 
strains to resist oxidative killing during infection, was found variable among 4 
different strains of B. cepacia. Differences of catalase activity were consistent 
with the strains’ susceptibility to oxidative killing. This may explain difference 
between strains of B. cepacia to oxidative killing. In addition, variations in 
catalase activity and resistance to oxidative killing between genomovars may 
also explain reason behind high virulence and transmissibility in CF with 
genomovar III but rare infectivity with genomovar I (Revets et al., 1996). The 
results from this study demonstrated that the catalase activity from B. cepacia 
strains when growing as biofilm, the way infectious bacteria grow in CF, were 
attenuated. Hence, the results of catalase activity open the gate for further 
aspects to be investigated:
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• Assay for catalase activity of planktonic and biofilm of B. cepacia when grown 
under iron limitation. This may indicate if iron which is essential, for catalase 
synthesis plays a role in catalase expression in B. cepacia strains.
• Since catalase was detected at mid-log as well as early stationary phase it may 
be quite novel to investigate if induction of monofunctional catalase is under the 
regulation of the RpoS regulon.
• It may be quite feasible if the A549 cell line could be used to test survival of B. 
cepacia when stimulated with pro-inflammatory cytokines in the presence and 
absence of IL-13 treatment.
In a first step towards investigating catalase expression at molecular level a 
deduced sequence of the structural catalase gene from B. cepacia J2315, that 
belongs to the most pathogenic group genomovar III, have been isolated, cloned 
and sequenced.
Understanding factors that contribute to the regulation of oxidative stress 
response should also aid in the dissection of host-pathogen interactions 
associated with CF respiratory infections. The catalase segment of the J2315, 
may be used in the future work to:
• Isolate and sequence regulatory genes upstream that are involved in the regulation 
of catalase expression. Investigate further, factor(s) that may induce the 
expression of these regulon(s) and eventually control catalase expression.
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• Study catalase gene expression related to B. cepacia biofilms to understand if the 
regulation of these genes under stress conditions.
• Sequnence the isolated and cloned 550bp deduced segment of B. cepacia J2552 
strain and screen the conserved amino acid residues and its homology to the 
sequenced B. cepacia J2315 strain. Since both strains exhibited different catalase 
activities and resistance to oxidative killing.
In conclusion, the data presented in this study have identified methods that can 
modulate synthesis of reactive nitrogen species from activated inducible nitric 
oxide synthase of pulmonary epithelial cells. In addition it demonstrated that 
strains of B. cepacia that are CF bacterial pathogens, have variable susceptibility 
to hydrogen peroxide. Furthermore, such findings contribute to a more thorough 
understanding of the host responses of the respiratory tract, and how they are 
disturbed in CF. It may allow a better understanding for methods to manipulate 
reactive nitrogen and oxygen species production and reactivity to improve the 
immunity in CF respiratory which may prevent or alleviate the fatal pulmonary 
disease in such patients.
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